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The use of plant-derived molecules to treat various forms of cancer has gained 
more and more attention in cancer research. In this study, we report that Polyphyllin 
D，a saponin naturally found in the plant Paris polyphylla, was shown to have potent 
anti-cancer effect against human hepatocellular carcinoma (HCC) cell line HepG2 and 
its derivative RHepG2 with multidrug resistance (MDR). The anti-cancer effects of 
Polyphyllin D in both cell lines in terms of cytotoxicity were higher than that of 
doxorubicin, a commonly-used anti-cancer drug. 
Investigation of the resistance mechanisms in untreated RHepG2 cells revealed 
that P -glycoprotein and Bcl-2 p roteins were u p-regulated. Results from o u r s tudy 
also show that the DNA sequence of the P-glycoprotein promoter in HepG2 and 
»» 
RHepG2 cells was identical indicating that the over-expression of P-glycoprotein in 
RHepG2 cells was not due to mutations in the promoter region. Surprisingly, 
Polyphyllin D is more effective in eliciting cell death in RHepG2 cells than in HepG2 
cells. Examination of the mechanism of cell death revealed that Polyphyllin D 
caused apoptosis in HepG2 and RHepG2 cells through the intrinsic mitochondrial 
pathway. This notion was supported by the evidence of (1) phosphatidylserine 
extemalization, (2) release of cytochrome c and apoptosis-inducing factor (AIF) from 
the mitochondria, (3) mitochondrial membrane depolarization and (4) release of 
reactive oxygen species after treatment with Polyphyllin D. 
In order to confirm mitochondria are the site of action of Polyphyllin D in cells, 
mitochondria from HepG2 and RHepG2 cells were isolated and treated with 
Polyphyllin D subsequently. Results showed that Polyphyllin D was able to act 
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directly on the isolated mitochondria to elicit mitochondrial membrane depolarization, 
mitochondrial swelling and release of cytochrome c. Again, mitochondria isolated 
from RHepG2 cells were more sensitive to Polyphyllin D than that from parental 
HepG2 cells. 
Moreover, results from flow cytometric analysis indicates that treatment of 
RHepG2 cells with a sub-lethal dose of Polyphyllin D (1.2|iM) for 6 days enhanced 
doxorubicin accumulation in RHepG2 cells with no change in the P-glycoprotein 
level on the cell surface. Furthermore, co-treatment of cells with Polyphyllin D and 
doxorubicin showed additive cytotoxic effects in RHepG2 cells. This suggests that 
combined treatment with Polyphyllin D and doxorubicin improved therapeutic effects 
and reduced the chance ofMDR development. 
In conclusion, Polyphyllin D is a potent and promising anti-cancer agent that can 
circumvent drug resistance and cause apoptosis in drug-sensitive and -resistant HCC 
cell lines through mitochondrial dysfunction. 















蛋白(P-glycoprotein)及Bcl-2蛋白含量比HepG2細胞中的高。此外’ D N A定 
序分析的結果顯示RHepG2細胞中P-糖蛋白特高是由於它的敌動子序列突變的 
機會不大。我們發現’ Polyphyllin D對引致R H e p G 2細胞的调亡比對H e p G 2 
細胞更為有效。對Polyphyllin D引致細胞调亡的機理進行研究時’我們發現 
Polyphyllin D能導致⑴填脂醯絲氨酸（phosphatidylserine)外露，⑵線粒體中的 
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細胞色素 c (cytochrome c)及 apoptotic inducing factor (AIF)從線粒體中釋出 ’（3) 
線粒體膜電位(mitochondrial membrane potential)下降，及(4)釋出活性氧物質 
(reactive oxygens pedes) °因it匕’我介3斷定Polyphyllin D食巨破壞線/粒體從而弓I 
致細胞调亡。 
為了證實Polyphyl l in D能直接影響線粒體，我們把線粒體從HepG2和 
RHepG2細胞中抽出，然後漫在有PolyphyllinD的等渗功效液體中°我們發現 
這樣也會引致線粒體脹大，細胞色素C(Cytochrome0從線粒體釋出及線粒體 





(1.2|iM)中養活六天之後再加入doxorubicin ’ R H e p G 2細胞中 d o x o r u b i c i n的含 
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Chapter 1 Introduction 
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Plant-based formulations have been used since ancient times as remedial 
measures against various aliments (Singh et ai, 2003). Plants produce an 
overwhelming variety of metabolites that are gaining importance for their therapeutic 
and biotechnological applications over the past twenty years (Quiroga et aL, 2001). 
This recent upsurge mainly roots from the increasing evidence demonstrating that 
plants are a rich source of unique compounds that are useful for therapeutic purposes. 
For example, Camptothecin from Camptotheca acuminate was found to kill cancer 
cells via topoisomerase I poisoning. First- and second-generation analogues of 
camptothecin are now being used to treat ovarian, colorectal and small-cell lung 
cancers (Oberlies et ai, 2004). Taxol from Taxus chinensis, on the other hand, was 
found to inhibit cancer cell growth via stabilization of microtubules. It is used to 
treat breast and non-small cell lung cancers and in Kaposi's sarcoma currently 
(Oberlies et aL, 2004). Other compounds found in other plants, such as indirubin in 
Indigofera tinctoria and harringtonine from Cephalotaxus hainanesis, were also found 
to have potent anti-cancer activities (Review: Han, 1994). 
In a search for potential anti-cancer agents from saponins, we found a saponin, 
called Polyphyllin D which naturally exists in the plant Paris polyphylla, can cause 
cell death in a human hepatocellular carcinoma cell line HepG2. However, the 
underlying mechanism for this cytotoxicity remains unclear. In light of this, the 
mechanism by which Polyphyllin D causes cell death in HepG2 cells, as well as its 
effects in the multi-drug resistant HepG2 derivative RHepG2 cells were investigated. 
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1.1 Saponins 
Saponins are a large family of secondary metabolites that are widespread 
throughout the Plant Kingdom. The name saponin is derived from sapo, a Latin 
word for soap, since these molecules have surfactant properties and give stable foams 
in aqueous solution (Haralampidis et ai, 2002). . 
1.1.1 Structure of saponins 
Saponin molecules are composed of two parts, a sapogenin and a carbohydrate 
chain. The carbohydrate chain may be attached to the sapogenin part as one, two or 
three side chains, and the resulting saponin is respectively called monodesmoside, 
bidesmoside and tridesmoside (Greek desmos = chain) (Figure 1.1.1.1). For the 
sapogenin, it can be further subdivided into two categories called steroid and 
triterpene sapogenin (Figure 1.1.1.2)，and the corresponding saponins are called 
steroidal saponin and triterpene saponin (Figure 1.1.1.3) (Hostettmann and Marston, 
1995). 
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C^OOH 
01c 膽 。 
Glc = D-glucose 
b) 
coo - Gk 
Ok —0 
Glc = D-glucose 
Figure 1.1.1.1 Sample structure of mono- and bi-desmoside saponin attached 
to a triterpene group, a) Mono-desmoside triterpene saponin; 
b) Bi-desmoside triterpene saponin. (Hostettmann and 
Marston, 1995). 
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Figure 1.1.1.2 Sample structure of a) steroid group; b) triterpene group. 
(Hostettmann and Marston, 1995). 







Glycyrrhizin R=gluA-(l-2)-gluA-(l-), R=CH3 




Yamogenin R=Ri=H, R2=CH3, R3=OH 
gluA = glucuronic acid 
Figure 1.1.1.3 Structure of a) the triterpene saponin glycyrrhizin; 
b) the steroidal saponin yamogenin. (Velisek, 1995). 
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1.1.2 Occurrence of saponins 
Saponins are present predominantly in plants (Oleszek, 2000), and in some 
marine animals such as the sea cucumber Eupentactafraudatrix (Makarieva etal, 
1993). Saponins are widely distributed in plant species, which exists in about 100 
plant families. They can be found in many edible plants like soya, beans and peas. 
Their concentration in plants ranges from traces up to 10% of dry matter (Oleszek, 
2000). In plants, saponins often occur as complex mixtures. Saponin content and 
composition may vary markedly depending on the genetic background, tissue type, 
age and physiological state of the plant and environmental factors (Kawai et ai, 1988). 
Saponins can be found in roots, shoots, flowers and seeds. Saponin distribution 
among different p lant tissues and p arts v aries c onsiderably in terms o f quality and 
quantity. (Hostettmann and Marston, 1995). 
Triterpene saponins are the most abundant class of saponin in nature. They are 
distributed in as many as 80 families. Triterpene saponins are rarely found in 
momocotyledons, but are abundant in dicotyledonous families, especially the 
Caryophyllaceae, Sapindaceaie, Polygalaceae and Sapotaceae (Hostettmann and 
Marston, 1995). . 
Steroidal saponins are less widely distributed in nature. They are mainly 
synthesized by monocotyledonous plants, particularly the Liliaceae, Dioscoreaceae 
and Agavaceae families. They are also present in dicotyledons such as Leguminosae 
and Solarium (Hostettmann and Marston, 1995). 
Chapter 1 Introduction 
Page 8 
1.1.3 Bioactivities of saponins 
Saponins have considerable potential as pharmaceutical and nutraceutical agents 
in natural or synthetic forms. Table 1.1.2.1 listed some beneficial effects of saponins 
from a number of in vitro and in vivo studies. For most of these studies, however, 
the mechanism of action is poorly understood (Rao and Gurfinkel, 2000). 
Table 1.1.2.1 Bioactivities of saponins. 
Saponin / Source of Reference 
Saponin 
Cardiovascular system 
Hypocholesterolemic effect Fenugreek Petit et al, 1995 
'Anti-coagulant effect Acanthopanax gracilistylus Chen et al., 1996 
van pubescens 
Cancer 
Anti-carcinogenic activity Treveria palmate De Tommasi et al., 2000 
Anti-mutagenic activity Ginseng ] Lee et al., 1998 
Hepatoprotective effect Red ginseng saponins Jeong et al” 1997 
Immunomodulatory Quillaja Sjolandere? al, 1998 
activity 
Neuroprotective effect Ginseng Yamaguchi et al., 1997 
Antioxidant activity . Soyasaponins Yoshiki et al., 1998 
Hypoglycemic activity Gymnema sylvestre Murakami et al., 1996; 
Yoshikawa et al., 1997 
Anti-inflammatory activity Argania spinosa Alaoui et al., 1998 
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1.2 Paris polyphylla (七葉一枝花） 
Polyphyllin D naturally occurs in the plant Paris polyphylla. Paris polyphylla 
(七葉一枝花)，common name “herb Paris" (http://www.hear.org), belongs to the 
Liliaceae family (www.gardeningdatabase.co.uk) (Figure 1.2.1). It is a rhizomatic 
plant that grows in mountain regions with cool temperature, and is found in the 
Himalayas from Northwest India to China (www.ganeshvilla.com). 
The rhizome oi Paris polyphylla is used in Traditional Chinese Medicine and is 
called Chonglou (重樓）(www.healthphone.com) (Figure 1.2.2), with the Latin name 
Rhizoma Paridis (http://herb.damo-qigong.net). To use, the rhizome is washed clean 
after cutting off the rootlets, and dried in sunlight or by fire (www.healthphone.com). 
Figure 1.2.1 Paris polyphylla (www.ganeshvilla.com) 
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Figure 1.2.2 Rhizoma Paridis (http://herb.damo-qigong.net) 
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1.2.1 Chonglou ( f i g ) 
In Chinese term, Chonglou is bitter with pungent flavour. It is slightly cold in 
property, and acts on the heart and liver. The effects of Chonglou include clearing 
away heat, detoxicating, subduling swelling and alleviating pain, dyspnea and cough 
(www.healthphone.com). 
In Chinese Medicine, Chonglou is used to treat tumours of the lung, stomach, 
liver, heart, urinary bladder and brain, leukemia and malignant lymphosarcoma. For 
hepatocellular carcinoma, it is often used with sun-plant, edible tulip bulb, 
cow-bezoare， pseudo-ginseng root, centi-pede, zedoary rhizome, etc. 
(www.healthphone.com). 
Chapter 1 Introduction 
Page 12 
1.3 Polyphyllin D 
Polyphyllin D (diosgenyl a-L-rhamnopyranosyl- (1 —> 2)-
(a-L-arabinofuranosyl)- (1—• 4)]-[p-D-glucopyranoside) is a steroidal saponin 
naturally found in Paris polyphylla (Figure 1.3.1). Since saponins have a relatively 
large molecular weight and are of high polarity, the isolation of saponins in high 
purity has been challenging. Moreover, that saponins often occur as complex 
mixtures with closely related compounds makes the isolation of pure saponins 
difficult (Hostettmann and Marston, 1995). Because of this, 28 saponin compounds 
were chemically synthesized by Professor B. Yu (俞酸，Shanghai Institute of 
Organic Chemistry, Chinese Academy of Science) and are named Hong Kong 
compounds (HK compounds) (Figure 1.3.2) based on the saponin structures present in 
Diao Xin Xue Kang (地奧心血康),a cardioprotective drug commonly used in China. 
The potency of HK compounds were tested in the HCC cell line HepG2, human 
breast cancer cell lines, MCF-7 and MDA-MB-231, and promyelocytic leukemia cell 
line HL-60. Results showed that the anti-cancer potency of Polyphyllin D (HK18) is 
I 
the highest among others. Moreover, when tested in the human normal liver cell line 
WRL-68, HK-18 has the least toxicity to the normal cells (Ms. Macey Lee's M. Phil 
Thesis). Owing to the high potency towards cancer cells and the low toxicity in 
normal cells, Polyphyllin D was employed for further studies. 
All HK compounds were totally organic synthesized with a purity of 99% (Deng 
et al,, 1999; Li et al 2001) in the form of powder and were stored at 4�C. The 
powder was dissolved in DMSO and then diluted with the buffer of the assay system. 
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1.4 Apoptosis 
1.4.1 Apoptosis and necrosis 
Generally, cell death is classified into two main categories: necrosis and 
apoptosis. Necrotic cell death occurs when cells suffer from damages like trauma, 
ischemia, and high dose of irradiation (Holdenrieder and Stieber 2004). During 
necrosis, necrotic cells swell and rupture, leading to the release of intracellular 
components into the surrounding tissue and thus inducing inflammatory response 
(Nelson and White, 2004). “ 
Apoptosis, on the other hand, is a well-organized cell program that involves 
initiation, execution, and termination phase. Apoptosis is a process important for 
—normal development and tissue homeostasis. Cancer results if there is too little 
apoptosis and at the same time cells proliferate faster and live longer than normal cells 
in an uncontrolled way (Sartorius et al., 2001; Schulze-Bergkamen and Krammer, 
2004). 
1.4.2 1 Initiation phase of apoptosis 
There are two main signaling routes in the initiation ofapoptosis, namely the 
extrinsic and intrinsic pathway (Figure 1.4.2.1). 
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Figure 1.4.2.1 Schematic representation of the intrinsic and extrinsic 
apoptotic pathways. The left represents the extrinsic death 
receptor pathway. The right outlined the intrinsic 
mitochondrial pathway. (Hengartner, 2000). 
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1.4.2.1 Extrinsic apoptotic pathway 
The initiation of the extrinsic pathway involves the binding of death receptor 
ligands to specific death receptors (DRs) on the cell surface. DRs are a subfamily of 
the TNF superfamily. They are characterized by a sequence with two to five 
cysteine-rich extracellular repeats. The death receptors share a homologous, 
intracellular death domain (DD) of about 80 amino acids, which is essential for the 
transduction of apoptotic signal (Sartorius et al., 2001). 
When agonist is bound, DRsoligomerize and recruit adaptor proteins such as 
TNF-receptor associated death domain (TRADD) or Fas-associating protein with 
death domain (FADD) through a homophilic interaction of the DD of DR and the DD 
^ of adaptor proteins. DR oligomerization results in the formation of death-initiating 
signaling complex (DISC) and thus the recruitment and auto-activation of pro-caspase 
8 into caspase 8，which is then released into the cytosol for the progression of 
apoptosis (Budihardjo et aL, 1999). 
Downstream of caspase 8, two signaling pathways can be activated, depending 
on the amount of active caspase 8 generated at DISC. In type I cells such as 
thymocytes (Ozoren et al., 2002), a large amount of caspase 8 is activated at DISC 
and allows the direct activation of the effector caspase 3. In type II cells like 
hepatocytes (Ozoren et aL, 2002), a small amount of caspase 8 is activated at DISC 
(Scaffidi et al., 1999). In these type II cells, the activated caspase 8 then cleaves Bid 
(a pro-apoptotic member of the Bcl-2 family) (Li et al,, 1998; Luo et cd., 1998; 
Scaffidi et al., 1999), causes its translocation and combination with Bax to activate 
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the intrinsic mitochondrial pathway, and thus amplifies the apoptotic signal 
(Holdenrieder and Stieber, 2004). 
1.4.2.2 Intrinsic apoptotic pathway 
In the intrinsic apoptotic pathway, mitochondria are the primary site of action. 
Upon DNA damage or stimulation with extracellular death stimuli, the amount ofpro-
and anti-apoptotic members of the Bcl-2 family change in a way that the ratio of these 
two types of molecules favours the death of the cell (Danial and Korsmeyer, 2004). 
Anti-apoptotic members of the Bcl-2 family proteins include Bcl-2 and BCI-XL, 
whereas Bax, Bak and Bid are the pro-apoptotic members of this family (Newmeyer 
and Ferguson-Miller, 2003). If the threshold of apoptosis is reached, apoptosis 
proceeds via the release of cytochrome c from the intermembraneous space of 
mitochondria. The released cytochrome c binds with Apaf-1 and pro-caspase 9 to 
form a complex called apoptosome. At the apoptosome, the caspase 9 is activated, 
which in turn activates executioner caspases like caspase 3 to carry out downstream 
processes (Li et al., 1997). 
• r 
1.4.3 Execution phase of apoptosis 
The activation of effector caspases brings about the hallmarks of apoptosis like 
DNA fragmentation, chromatin condensation, membrane blebbing, etc. For instance, 
caspase 3 cleaves gelsolin, a cytoplasmic actin-severing protein, which may 
contribute to membrane blebbing and DNA fragmentation (Kothakota et aL’ 1997). 
Another substrate of caspase 3 is the caspase-activated DNase (CAD), or DNA 
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fragmentation factor (DFF). CAD/DFF is responsible for both large-scale DNA 
fragmentation and nucleosomal DNA fragmentation (Nagata, 2000). Caspase 6, on 
the other hand, degrades lamin B and leads to the disassembly of the nuclear envelop 
and the final collapse of the cell nucleus (Rao et al., 1996). 
Independent of caspase activation, apoptosis-inducing factor (AIF) and 
endonuclease G (endoG), which are released from mitochondria during apoptosis, 
initiate both chromatin condensation and large-scale DNA fragmentation (Daugas et 
al., 2000; Schafer et al., 2004). 
1.4.4 Termination phase of apoptosis 
, In the termination phase of apoptosis, the dying cells present specific surface 
molecules on cell surface. Scavenger cells like macrophages recognize these surface 
molecules and engulf the apoptotic cell. The best characterized surface molecule 
presented by apoptotic cells is phosphatidylserine (PS), an anionic phospholipid 
usually confined to the interior of the cell but externalized to the outer side of plasma 
membrane in response to oxidation by cytochrome c released from mitochondria 
during apoptosis (Hengartner, 2001; Kagan et al., 2000). Other molecules include 
the carbohydrate N-acetylglucosamine, vitronectin, and fibronectin. Phagocytic 
removal of apoptotic cells is essential in protecting tissue from inflammatory injury 
caused by leakage of harmful contents from the dying cells (Bergmann and Steller, 
2002). 
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1.5 Multi-drug resistance 
Multi-drug resistance (MDR) is a generic term for a variety of strategies that 
tumour cells used to evade the cytotoxic effects of anti-cancer drugs. MDR is 
characterized by a decreased sensitivity of tumour cells not only to the drug employed 
for chemotherapy, but also to a broad spectrum of drugs with neither obvious 
homology nor common targets (Simon and Schindler, 1994). 
The view that the mechanisms of MDR are opportunistic in their modification of 
normal cellular homeostasis pathways is now widely embraced. However, the 
molecular and metabolic mechanisms of MDR are not fully understood. Resistance 
to anti-cancer drugs can be mediated by a number of mechanisms operating at 
’, different steps of drug action, from the decrease in drug accumulation in cells to the 
onset and execution of apoptosis. Often, several different mechanisms work 
simultaneously in the MDR cells, but usually one major mechanism plays a more 
significant role in the cells (Stravrovskaya, 2000). 
1.5.1 MDR mediated by decreased drug accumulation 
Decrease of drug accumulation in cells may be a result of both reduced drug 
influx and an increased drug efflux. Since most chemotherapeutic drugs enter cells 
by passive diffusion through the plasma membrane, changes in plasma membrane 
constituents may affect the diffusion of drug molecules into the cells. Indeed, it has 
been found that the lipid composition in plasma membrane is altered in MDR cells 
(Hendrich and Michalak, 2003). The modifications could cause either changes in 
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drug traffic through the cell membrane, or an influence on signaling pathway 
controlling apoptosis. However, data concerning alternations of drug uptake by cells 
are scarce, so another mechanism, drug efflux from MDR cells, is considered to be 
the principal mechanism of decreased drug accumulation in cells (Stravrovskaya, 
2000). 
Drug efflux is mediated by the expression of transporter proteins on the plasma 
membrane. Up to now several transport proteins were reported to play a role in 
MDR. Among them, proteins in the superfamily of transport proteins known as the 
ATP-binding cassette (ABC) transporters are most frequently studied. These 
transporters include P-glycoprotein (Figure 1.5.1.1) and the multidrug resistance 
protein (MRP) (Leonard et al” 2003). Other proteins not in the ABC transporter 
family, such as lung-resistance-related protein (LRP), are also found to be involved in 
MDR (Stavrovskaya, 2000). 
P-glycoprotein is a 170kDa organic cation pump which comprises 12 
transmembrane segments divided into 2 transmembrane domains, each linked with an 
ATP-binding domain (Stravrovskaya, 2000). Binding of a substrate to the 
high-affinity b inding.s ite r esults i n ATP h ydrolysis, w hich c auses a c onformational 
change that shifts the substrate to a lower affinity binding site and then releases it into 
the extracellular space (Sauna et al, 2001). P-glycoprotein confers resistance 
against a wide spectrum of compounds. Typical P-glycoprotein substrates are 
hydrophobic or amphiphilic molecules with a planar ring system and molecular 
Weight over 400, and are positively charged at pH 7.4, although compounds without 
these features are also found to be substrates of P-glycoprotein (Sharom, 1997; 
Chapter 1 Introduction 
Page 23 
Ambudkar et al, 1999). 
P-glycoprotein is encoded by the MDRl gene. The MDRl gene has two 
promoters, the downstream and upstream promoters. In tissues and cultured cells, 
the expression of the downstream promoter is usually found. Thus, the downstream 
promoter is considered as a basic element regulating the activity of the MDRl gene 
(Ueda et al., 1987b). Transcription of the MDRl gene is influenced by a number of 
factors. Transcription is increased by drugs in chemotherapy, including those which 
are not P-glycoprotein substrates, which impeded cancer treatment for a long time 
(Chaudhary and Roninson, 1993). 
MRP is another transmembrane protein with a molecular weight of 190kDa. It 
is similar in structure with P-glycoprotein and they share an overlapping substrate 
spectrum. In contrast to P-glycoprotein, the functioning of MRP requires cellular 
glutathione and MRP is one of the transporters of glutathione conjugates (the GS-X 
pumps) (Deeley and Cloe, 1997; Borst et al., 1997). 
LRP is an 11 OkDa protein which, is found in the cytoplasm rather than plasma 
membrane in contrast to P-glycoprotein and MRP. The function of LRP is not fully 
elucidated, but it is believed to be involved in intracellular redistribution of drugs, 
possibly by sequestration into vesicles, thus reducing the interaction of drug 
molecules with drug targets (Izquierdo et aL, 1996; Zurita et al., 2003). 
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Figure 1.5.1.1 Schematic structure of P-glycoprotein and some examples of 
its substrates. (Adapted from Sorrentino, 2002) 
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1.5.2 MDR mediated by enhanced anti-oxidant enzyme activities 
Anti-cancer d rugs 1 ike anthracyclins lead to the generation o f r eactive o xygen 
species (ROS), which partly contributes to their cytotoxic effects in cancer cells 
(Sinha & Mimnaugh 1990). In many cases, cells resistant to the treatment of these 
drugs are accompanied by the up-regulation of anti-oxidant enzymes such as 
manganese superoxide dismutase (MnSOD) (Hur et aL, 2003; Manna et al., 1998; 
Hirose et al； 1993; Wong et al” 1989), glutathione S-transferase (GST) (Lee et al., 
1996)，and glutathione peroxidase (GPx) (Gouaze et al” 2004; Lee et al., 1996). 
Although the increase in anti-oxidant enzyme cannot completely account for the 
resistance of cancer patients to a treatment, these data indicate that increased 
anti-oxidant capacity may partly explain the resistance to a number of treatment 
modalities. 
*t 
1.5.3 MDR mediated by enhanced detoxification of drugs 
The cellular glutathione system is a critical component of detoxification of 
xenobiotics in cells. Glutathione is a non-protein thiol which can interact with the 
active site of a drug with its thiol group, resulting in the conjugation of the drug with 
glutathione. This conjugation process makes the drug less active and more soluble 
in water, and the conjugate can then be excluded from the cell with the participation 
of the GS-X transporter proteins like MRP (Stavrovskaya, 2000). Increased levels of 
glutathione were found in cell lines resistant to alkylating agents like nitrogen mustard 
(Tew, 1994). 
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1.5.4 MDR mediated by enhanced DNA repair systems 
Many anti-cancer drugs cause cell killing by inducing DNA damages. The 
resistance of cancer cells towards DNA-damaging agents has been reported. There 
are four m ain D NA repair m echanisms i n c ells. They i nclude d irect D N A r epair, 
base excision repair, nucleotide excision repair, and mismatch repair (Reed, 1998; 
Buermeyer et al., 1999; Frosina, 2000; Pegg, 2000). 
Enhanced nucleotide excision repair for bifunctional DNA adducts and enhanced 
direct repair mediated by 0^-alkylguanine DNA alkyltransferase was found to be the 
cause of platinum drugs and chloroethylnitrosoureas resistance respectively (Reed, 
1998; Pegg, 2000). Defects in mismatch repair, which contribute to the development 
一 of cancer, were found to cause resistance to a number of anti-cancer drugs as well as 
ionizing radiation (Sedwick et al, 1999). The importance of base excision repair in 
MDR, however, remains elusive (Chaney and Sancar, 1996). 
1.5.5 MDR mediated by altered apoptotic pathway 
Induction of apoptosis is one of the main mechanisms by which cytotoxic drugs 
eliminate cancer cells. Defects in apoptotic pathways have been a common way that 
MDR cells evade the cytotoxicity of anti-cancer drugs. Alternations in various key 
molecules in apoptosis were reported to be associated with drug resistance. The p53 
protein is responsible for inducing cell cycle arrest or apoptosis upon DNA damage. 
It has been found that resistance to 5-flouroucial can be reversed by 
adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human 
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colon carcinoma in vitro (Yu et al., 2004). Also, cancers that contain wile type p53 
expression are more likely to respond to chemotherapy than other tumour types 
(Schulze-Bergkamen and Krammer, 2004). 
The mitochondrial apoptotic pathway is regulated by members of the Bcl-2 
family (Gross et al., 1999; Kroemer, 1999). The ratio of pro- to anti-apoptotic 
members of this family determines a threshold for induction of apoptosis (Zha et al., 
1997; Korsmeyer, 1999; Reed, 1998; Huang and Strasser, 2000; Lutz, 2000; Cheng et 
al, 2001; Stoetzer et al, 1996). The use of Bcl-2/Bax ratio as a prognostic factor in 
patients treated with chemoradiotherapy has recently been suggested (Matsumoto et 
al., 2004). Two groups of researchers showed that cells without the pro-apoptotic 
Bax protein are resistant to mitochondria-mediated apoptosis (Zhang et al., 2000; 
,Schmitt and Lowe, 2002). On the contrary, over-expression of the anti-apoptotic 
BC1-XL and Bcl-2 proteins suppressed apoptosis (Walczak et al, 2000; Schott et al., 
1995), and down-regulation of Bel- Xl or Bcl-2 enhanced the apoptotic response to 
DNA-damage (Hayward et al., 2004). 
1.5.6 Current strategies for overcoming multidrug resistance in cancer 
‘Current strategies against MDR are intended to reverse, overcome, or prevent the 
development of resistance in cancer cells. Contemporary treatment of tumours with 
resistance i nchides t he u se o f s econd- o r t hird-line d rugs w ith 1 ess cross-resistance 
with the primary drug employed. In a study of this strategy, Parmar and co-workers 
(2003) reported that taxol (paclitaxel) plus platinum chemotherapy improved survival 
of patients with combined chemotherapy. 
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Beside combined therapy with non-resistant agents, sequential therapy is also 
employed. In sequential therapy, one agent is used initially and then treatment is 
switched to another drug in order to eliminate cells that may have developed 
resistance so that the initial therapy can be used without diminished efficacy later. 
Potential advantages are that full doses of the most potent agent can be administered 
initially and reduced sensitivities of cancer cells to certain agents can be exploited. 
The advantage of this approach over combined treatment is that negative interactions 
between drugs can be prevented (Vasey, 2003). Success of this approach has been 
proved in vitro acute leukemia cell model (Karp et al., 2003) and in patients with 
HCC (Huo etal., 2003). 
Several molecular strategies targeting apoptosis-related proteins have been 
suggested to overcome MDR. Introduction of the pro-apoptotic Bax gene into in 
vitro ovarian cell line (Strobel et al” 1996), and in vitro (Kim et al., 2000) and in vivo 
(Kim et al., 2001) gastric cancer cells has been shown to enhance the sensitivity of 
cells to several drugs and apoptosis. Similar effects have been observed in cells 
transfected with Bcl-Xs and Bad (Sumantran et al., 1995; Strobel et al, 1998). 
Down-regulation of anti-apoptotic members of the Bcl-2 family proteins, on the other 
hand, has also shown to be feasible in cancer therapy. Modulation of drug sensitivity 
by co-treatment with antisense phosphorothioate oligonucleotides of Bcl-2 has been 
reported in lymphoma and melanoma and was shown to increase tumour response to 
the cancer therapy used (Webb et al., 1997; Jansen et al, 2000). 
To prevent the emergency of MDR, a potential strategy may be the 
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administration of transporter inhibitor at the beginning of chemotherapy (Gottesman 
et al., 2002), although the reversal agent may itself increase the side effects of 
chemotherapy by affecting the normal functioning of transporters in normal cells. 
Similarly, co-administration of a second agent to inhibit the resistance mechanism 
may add adverse effects on the patients. 
Alternatively, designing anti-cancer drugs that can overcome resistance 
mechanisms may be a more direct approach against MDR. Several anti-cancer drugs 
have gain at least partial success in achieving this. Amsacrine, an 
anti-topoisomerase II agent, overcomes P-glycoprotein-mediated MDR to some extent. 
The reason for this phenomenon is likely to be the high degree of lipophilicity of 
amsacrine, which leads to an extremely rapid uptake into cells so that the outward 
drug transports by transporters can be compensated (Robbie et al., 1988). Another 
drug, DACA (N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide), is highly 
effective in overcoming both P-glycoprotein and MRP-mediated resistance. Again, 
its success is also related to its high degree of lipophilicity and high rate of cellular 
uptake (Davey et al, 1997). Therefore, increasing the lipophilicity of drugs may be 
a feasible approach to overcome MDR in cancer cells. 
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1.6 Hepatocellular carcinoma (HCC) 
Hepatocellular carcinoma (HCC) is the third commonest cause of cancer 
mortality worldwide. It causes over 500,000 deaths each year in the world. The 
mortality rate of HCC ranges from 1/100,000 per year in Northern Europe to 
20/100,000 per year in Asia-Pacific region (Nowak et al., 2004). The majority of 
HCC is caused by viral hepatitis, either hepatitis C or hepatitis B, so theoretically 
HCC can be at least partly prevented by controlling viral infection (Omata and 
Yoshida, 2004). 
Surgical resection and systemic chemotherapy are standard treatments for hepatic 
disease. Unfortunately, only 10-20% of patients are suitable for resection (Johnson, 
2002). Since HCC has a high incidence of expression of the multi-drug resistance 
protein P-glycoprotein, poor response is often resulted in chemotherapy. Indeed, 
over-expression ofP-glycoprotein was found in tumour from 86% ofpatients with 
HCC (Grude et al., 2002). In addition, the impaired liver function in HCC patients 
further intensifies the toxicity of anti-cancer drugs in the patient (Nowak et al., 2004). 
An alternative therapy for patients with HCC is hepatic arterial infusion (HAI) 
chemotherapy. HAI chemotherapy is the infusion of a chemotherapeutic drug 
through the hepatic artery directly into the liver. The major advantage of HAI over 
systemic chemotherapy is the possibility to achieve higher drug concentrations in the 
tumour site while reducing systemic exposure and side effects. One of the main 
concerns regarding HAI chemotherapy is its complications (Bamett and Malafa， 
2001). They include myelosuppression, mucositis, emesis, and diarrhea. However, 
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these side effects are generally not as severe as those produced by systemic 
chemotherapy (Barber et al； 2003). 
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1.7 Objectives of Project 
In this project, the effects of the steroidal saponin Polyphyllin D on the induction 
of cell death in human HCC HepG2 cells and its derivative with 
doxorubicin-resistance (RHepG2 cells) were investigated. 
Since MDR has been a major impediment in cancer therapy, we would like to 
know whether Polyphyllin D can reverse the MDR properties in RHepG2 cells. In 
this regard, the MDR mechanisms in RHepG2 cells was first examined. Also, the 
effects of Polyphyllin D on the reversal of MDR mechanisms in RHepG2 cells were 
studied. 
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Materials and Methods 
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2.1 Materials 
2.1.1 Culture of Cells 
2.1.1.1 Cell lines 
Two cell lines, the human hepatocellular carcinoma (HCC) cell line HepG2 and 
the multi-drug resistant derivative RHepG2, were employed in this study. HepG2 
cells (ATCC number HC-8065) were purchased from American Type Culture 
Collection. They were obtained from a 15-year-old Caucasian boy and showed no 
evidence of hepatitis B genome in cells. They have adherent characteristics and 
were maintained in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine 
serum and 1 % penicillin-streptomycin (v/v) (complete medium) at 3 7°C, 5 % C 0 2 
incubator (SHEL LAB) with humidified atmosphere. Generally, HepG2 cells were 
kept in 25, 75 or 150cm^ culture flasks and were passed every 3 or 4 days after 
growing to confluence. In each passage, the used medium was discarded. Cells were 
then washed with PBS once and trypsin was added to release adherent cells from the 
culture flask. Complete medium was then added and resuspended cells were 
collected. Centrifugation was carried out at 453 x g (1,500 rpm, 16.0 cm, 
Eppendorf Centrifuge 581 OR) for 3 minutes. Pellet of cells was then suspended in 
complete medium and passed to a new culture flask for future use. 
RHepG2 cells are the multi-drug resistant derivative of HepG2 cells. To 
develop RHepG2 cells, HepG2 cells were grown with 0.1 |iM doxorubicin. Dead 
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cells were discarded and viable cells were further incubated with stepwise increasing 
concentrations of doxorubicin up to lOO i^M. Culture of RHepG2 cells was similar 
to that of HepG2 cells except that 1.2^M doxorubicin was added to complete 
medium at each passage to maintain the MDR properties of RHepG2 cells. 
2.1.1.2 Preservation of Cells 
Generally, cells were kept in freezing mixture as the frozen stock in liquid 
nitrogen. The freezing mixture was composed of 50% FBS (v/v), 40% complete 
medium (v/v) and 10% DMSO (v/v). Cells were harvested from the culture flasks 
with the use of trypsin and were suspended with complete medium. Centrifugation 
” was then carried out at 453 x g (1,500 rpm, 16.0 cm, Eppendorf Centrifuge 581 OR) 
for 3 minutes. Three million cells were suspended in 1 ml of freezing mixture and 
were transferred to freezing vials (Nalgene, USA). Cells were then cooled at -20°C 
until frozen and then stored at -70°C overnight. Afterwards, cells were stored in 
liquid nitrogen until use. To thaw the cells, cells were thawed quickly in 3TC 
water bath and suspended in 30ml pre-warmed complete medium. The medium 
with cells was then transferred to a new culture flask. On the other day, medium in 
the flask was disposed and the flask was filled in fresh complete medium. 
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2.1.2 Culture Media 
2.1.2.1 RPMI1640 (Phenol Red Medium) 
RPMI (Rosewell Park Memorial Institute) 1640 was used to culture both 
HepG2 and RHepG2 cells. It contains phenol red, L-glutamine and 0.5mM HEPES. 
The powder of RPMI was dissolved in IL of 啦。and supplemented with 24mM 
NaHCOs. The pH of the medium was adjusted to 7.4. Then, the medium was 
sterile filtered with the use of 0.22|im cellulose acetate membrane bottle-top filter. 
(7111, Falcon, Becton Dickinson, NJ, USA). The medium was then supplemented 
with 10% FBS and 1% penicillin-streptomycin for cell culture. The complete 
medium was stored at 4°C. 
2.1.2.2 RPMI 1640 (Phenol Red-free Medium) 
Phenol red-free RPMI medium (pRPMI) consisted of L-glutamine without 
phenol red or HEPES. The powder of phenol red-free RPMI was dissolved in 1L of 
dHzO and supplemented with 24mM NaHCOa and 25mM HEPES. The pH of the 
medium was adjusted to 7.4. Then, the medium was sterile filtered with the use of 
0.22|im cellulose acetate membrane bottle-top filter. The colorless medium was 
supplemented with 1% penicillin-streptomycin and stored at 4°C. 
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2.1.3 Buffers and Reagents 
Buffer was prepared from dissolving chemicals in distilled water (dH20) and 
titrated to suitable pH with either HCl or NaOH, unless otherwise specified. 
2.1.3.1 Buffer for Common Use 
Phosphate buffered saline (PBS) was prepared by using 2.7mM KCl, 1.5mM 
KH2PO4, 136mM NaCl and 8mM NazHPCU. The pH was adjusted to 7.4. PBS was 
made sterile by autoclave and then stored at room temperature. 
„ 2.1.3.2 Reagents for Annexin-V-FITC/Propidium iodide (PI) Assay 
Annexin-V-Fluos labeling solution (Annexin-V) was purchased from 
Boehringer Mannheim. It was stored as aliquots at -20°C (Manual of Boehringer 
Mannheim). Repeated thawing and freezing were avoided. 
Incubation buffer was prepared with lOmM HEPES, 140mM NaCl and 5mM 
CaClz. The pH was adjusted to 7.4. 
2.1.3.3 Reagents for Western Blotting Analysis 
Lysis buffer for total protein extraction was prepared with ImM NasVCU, 1% 
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(w/v) SDS, lOmM Tris. The pH was then adjusted to 7.4 and stored at room 
temperature. Prior to the lysis of cells, the lysis buffer was supplemented with 
5mM MgCli, ImM PMSF, 21|^g/ml aprotinin, and 5}ig/ml leupeptin. 
Lysis buffer for cytosolic protein extraction was prepared with 75mM NaCl, 
ImM NaH2P04，8mMNa2HP04, and 250mM sucrose. The buffer was stored at 
4�C. Prior to the lysis of cells, the buffer was supplemented with ImM PMSF, 
21]Lig/ml aprotinin, 5|dg/ml leupeptin and various concentrations of digitonin. 
4X lower gel buffer was prepared with 1.5M Tris base and 14mM SDS. The 
pH of the buffer was adjusted to 8.8 and stored at 4°C. 
4X upper gel buffer was prepared with 0.5M Tris base and 14mM SDS. The 
pH of the buffer was adjusted to 6.8 and stored at 4°C. 
12% separating gel buffer was freshly prepared with 40% (v/v) 
acrylamide/bis-acrylamide (30%) solution, 25% (v/v) 4X lower gel buffer, 0.05% 
(w/v) ammonium persulfate and 0.12% (v/v) TEMED. 
4.5% stacking gel buffer was freshly prepared with 15% (v/v) 
acrylamide/bis-acrylamide (30%) solution, 25% (v/v) 4X upper gel buffer, 0.07% 
(w/v) ammonium persulfate and 0.13% (v/v) TEMED. 
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2X SDS loading buffer was prepared with 2% (w/v) SDS, 10% (w/v) sucrose, 
0-002% bromophenol blue and 62.5mM Tris. The pH of the buffer was adjusted to 
6.8. Buffer was supplemented with 5% (v/v) 2-mercaptoethanol and stored at 4®C. 
SDS running buffer was prepared with 25mM Tris base, 192mM glycine and 
0.1% (w/v) SDS and stored at room temperature. 
Electroblot buffer was freshly prepared with 48mM Tris base, 39mM glycine, 
20% (v/v) methanol and 0.0375% (w/v) SDS. The pH of the buffer was adjusted to 
9.2 to 9.4. 
“ TBS-Tween-20 (TBS-T) was prepared with lOmM Tris base, 0.15M NaCl and 
0.1 o/o (v/v) Tween-20 and stored at room temperature. The pH of the buffer was 
titrated to 8.0. 
Mitochondria buffer was prepared with lOmM HEPES, lOmM Succinate, 
215mM Mannitol, 220mM Sucrose, 0.05%(w/v) BSA, 0.8mM Potassium Phosphate, 
1 mM EGTA. The pH of the buffer was adjusted to 7.4. 
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2.1.4 Chemicals 
Polyphyllin D was dissolved in DMSO to prepare a 50mM stock solution 
and then diluted with the medium in use. 
Doxorubicin was prepared by dissolving in 1 ml autoclaved distilled water 
and was then diluted into ImM stock with PBS. It was stored at -20°C and 
protected from light. 
Taxol was dissolved in DMSO to give a stock concentration of 5mM. The 
stocks were kept at —20�C in darkness. 
HK-Pl was dissolved in DMSO to prepare a lOmM stock solution and 
then diluted with the medium in use. 
2.1.4.1 Fluorescence Dyes 
- JC-1 (5, 5', 6，6，-tetrachloro-l, 1，，3, 3‘-tetraethylbenzimidazolcarbocyanine 
iodide), DCF [5-(and 6-)-carboxy-2‘,7-dichlorodihydrofluorescein diacetate] and 
‘propidium iodide (PI) were prepared by dissolving in (DMSO) and were stored at 
-20°C. These stock solutions are at 1 east 1 000 times more c oncentrated than the 
working concentration so that the influence of DMSO on the assay system is 




Table 2.1.4.2.1 A list of primary antibodies used in this study 
Antibody Dilution used Storage temperature Source 
Anti-p-tubulin 1:1000 -20�C Calbiochem, CA, 
USA 
Anti-Grp75 1:1000 ？C Santa Cruz 
Biotechnology, Inc. 
Anti-cytochrome c 1:1000 4 � C Pharmingen 
Anti-Bcl-2 1:1000 4°C Santa Cruz 
' Biotechnology, Inc. 
Anti-Bax 1:1000 ^ Santa Cruz 
Biotechnology, Inc. 
Anti-lamin B 1:1000 4°C Santa Cruz 
Biotechnology, Inc. 
Anti-AIF 1:1000 ？C Santa Cruz 
‘ Biotechnology, Inc. 
Anti-P-glycoprotein 4 � C Calbiochem, CA, 
‘ USA 
： L 
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Table 2.1.4.2.2 A list of secondary antibodies used in this study 
Antibody Dilution used Storage temperature Source 
Anti-mouse-HRP ：^工⑷。 4°C Santa Cruz 
Biotechnology, Inc. 
Anti-rabbit-HRP " " " ^ ^ ^ Santa Cruz 
Biotechnology, Inc. 
Anti-goat-HRP ！：誦 ^ Santa Cruz 
Biotechnology, Inc. 
Anti-mouse-FITC 1:100 -20°C Calbiochem, CA, 
USA 
2.1.4.3 Other Chemicals 
f 
Aprotinin, leupeptin, PMSF and ammonium persulfate were used. Aprotinin 
and leupeptin were dissolved in dHzO and stored at -20�C. PMSF was dissolved in 
absolute ethanol and stored at -20°C. Ammonium persulfate was dissolved in dUiO 
and stored at 4°C. 
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2.1.5 Summary of chemicals used in this study 
Table 2.1.5.1 A list of common, chemical name and formula used in this study 




2-mercaptoethanol 78.13 Sigma Chemical Co., St. 
(C2H6OS) Louis, MO, USA 
Acrylamide/bis-acrylamide / Sigma Chemical Co., St. 
(30% solution, mix ratio 37.5:1) Louis, MO, USA 
Agarose / Sigma Chemical Co., St. 
Louis, MO, USA 
Albumin, Bovine / Sigma Chemical Co., St. 
(BSA, initial fractionation by cold alcohol Louis, MO, USA 
precipitation, Fraction V 96-99% albumin) 
Ammonium persulfate 228.2 BIO-RAD Laboratories 
Annexin-V-Fluos labeling solution / Boehringer Mannheim, 
Germany 
Aprotinin / Sigma Chemical Co., St. 
(3 - 7 TIU (trypsin inhibitor unit)) Louis, MO, USA 
BCA / Sigma Chemical Co., St. 
(Bicinchoninic acid solution) Louis, MO, USA 
Bromophenol blue 691.9 Sigma Chemical Co., St. 
(C19H9Br405SNa) Louis, MO, USA 
Chloroform 119.38 Merck, Germany 
(CHCI3) 
Copper (II) sulfate pentahydrate / Sigma Chemical Co., St. 
(CUSO4-5H2O) (4% (w/v) solution) Louis, MO, USA 
DCF 487 Molecular Probes, Eugene, 
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(5-(and Oregon, USA 
6-)-carboxy-2 ‘ ,7-dichlorodihydrofluorescein 
diacetate) (carboxy-H2DCFDA) 
Digitonin 1228 Merck, Germany 
(C56H92O29) 
DMSO 78.13 BDH Chemicals Ltd., 
(dimethylsulphoxide) (CH3SOCH3) Poole, England 
DNA marker (250 base pair) ladder / Shenergy Biocolor 
Bioscience & Technology 
Co., Ltd, Shanghai, China 
dNTP mix / Sangon Biologic 
Engineering Technology 
and Service Co., Ltd, 
Shanghai, China 
Doxorubicin 579.98 Sigma Chemical Co., 
(C27H29NO11.HCI) 
ECL reagents / Amersham Pharmacia 
.(Enhanced chemiluminescence reagents) Biotech 
Ethanol 46.07 BDH Chemicals Ltd., 
(EtOH) (C2H5OH) Poole, England 
EDTA 292.2 Sigma Chemical Co., St. 
(Ethylenediaminetetraacetic acid) (CipHieNzOs) Louis, MO, USA 
EGTA 380.35 Sigma Chemical Co., St. 
(Ethylene-bis(oxyethylenenitrilo)tetraacetic acid) Louis, MO, USA 
( C 1 4 H 2 4 N 2 O 1 0 ) ； 
Fetal Bovine Serum / GibcoBRL, Life 
(FBS) “ Technologies Inc. 
Glucose 180.2 Sigma Chemical Co., St. 
(C6H12O6) - Louis, MO, USA 
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Glycine | 7 5 . 0 7 [ u ^ (United States 
(H2NCH2CO2H) •• Biochemical), Cleveland, 
OH, USA 
HEPES 238.8 Sigma Chemical Co., St. 
(N-[2-hydroxyethl]piperazine-N'-[2-ethanesulfonic Louis, MO, USA 
acid]) 
HK-Pl 1214.53 Prof. B. Yu • 
Hydrochloric acid 36.45 BDH Chemicals Ltd., 
(HCl) Poole, England 
Isoamyl alcohol 88.15 Riedel-de Haen, AG, 
(3-methyl butanol-(l)) (C5H12O) Germany 
JC-1 652 Molecular Probes, Eugene, 
(5, 5', 6, 6'-tetrachloro-l, 1，， 3, Oregon, USA 
3 ‘ -tetraethylbenzimidazolcarbocyanine iodide) 
Leupeptin 463 Sigma Chemical Co., St. 
(C20H38N6O4) Louis, MO, USA 
Magnesium chloride 203.3 Sigma Chemical Co., St. 
.(MgCb) Louis, MO, USA 
Magnesium sulfate-7-hydrate 246.48 BDH Chemicals Ltd., 
(MgS04-7H20) Poole, England 
Mannitol 182.17 Sigma Chemical Co., 
(CeHuOe) 
Methanol 32.04 BDH Chemicals Ltd., 
(CH3OH) Poole, England 
Molecular sieve ‘ / Sigma Chemical Co., St. 
(Potassium, Sodium alumino-silicate) (nominal Louis, MO, USA 
pore diameter: 3 angstrom) 
Non-fat milk / Carnation, Nestle 
Penicillin-streptomycin / GibcoBRL, Life 
(penicillin: 5000 U/ml protein Technologies Inc. 
streptomycin: 5000 g/ml) 
Phenol 94.11 U ^ (United States 
(C6H5OH) Biochemical), Cleveland, 
|0H, USA 
Chapter 2 Materials and Methods 
Page 46 
PMSF 174.2 Sigma Chemical Co., St. 
(phenylmethyl-sulfonyl fluoride) (C7H7FO2S) Louis, MO, USA 
Polyphyllin D 855.02 Prof. B. Yu 
(diosgenyl a-L-rhamnopyranosyl- ( 1 • 2 ) -
(a-L-arabinofuranosyl)- (1 ~ • 4)] 
-[(3-D-glucopyranoside) 
Potassium chloride 74.55 Sigma Chemical Co., St. 
(KCl) Louis, MO, USA 
Potassium phosphate 136.1 Sigma Chemical Co., St. 
(monobasic anhydrous) (KH2PO4) Louis, MO, USA 
Propidium iodide 668.4 Sigma Chemical Co., St. 
(PI) Louis, MO, USA 
RPMI / GibcoBRL, Life 
(with phenol red) Technologies Inc. 
RPMI / GibcoBRL, Life 
(without phenol red) Technologies Inc. 
SDS 288.38 USB (United States 
(sodium dodecyl sulfate) (CH3(CH2)iiS04Na) Biochemical)， Cleveland, 
OH, USA 
Sheath fluid / Becton Dickinson, NJ, 
Sodium chloride 58.44 USB (United States 
(NaCl) Biochemical), Cleveland, 
OH, USA 
Sodium dihydrogen phosphate 156.01 Riedel-de Haen, AG, 
(NaH2P04) Germany 
Sodium hydrogen carbonate 84.01 Sigma Chemical Co., St. 
(NaHCOs) Louis, MO, USA 
Sodium hydrogen phosphate 141.96 Sigma Chemical Co., St. 
(NazHPCU) Louis, MO, USA 
Chapter 2 Materials and Methods 
Page 47 
Sodium hydroxide 40.00 Sigma Chemical Co., St. 
(NaOH) ； Louis, MO, USA 
Sodium orthovanadate 183.9 Sigma Chemical Co., St. 
(Na3V04) Louis, MO, USA 
Succinate 270.14 Sigma Chemical Co., 
(•4_3204. 6H2O) 
Sucrose 342.3 Sigma Chemical Co., St. 
(C12H22O11) Louis, MO, USA 
Taq polymerase / Roche Applied Science, 
(Expand High Fidelity Plus PGR System) Germany 
Tris 121.14 USB (United States 
(NH2C(CH20H)3) Biochemical), Cleveland, 
OH, USA 
Trypsin-EDTA / GibcoBRL, 
(O.250/0 trypsin, ImM EDTA) Technologies Inc. 
Tween-20 / Sigma Chemical Co., St. 
(polyoxyethylene-sorbitan monolaurate) Louis, MO, USA 
f 
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2.2 Methods 
2.2.1 In vitro Cell Cytotoxicity Assay 
2.2.1.1 AlamarBlue Assay 
AlamarBlue assay was used to determine cytotoxicity in recent years because it 
had more advantages than MTT assays (Gloeckner et al., 2001). The principle of 
alamarBlue assay is based on the reduction of a fluorometric/colorimetric 
oxidation-reduction (REDOX) indicator during cell growth. 
Procedure: 
• HepG2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 96-well 
plate with 100 complete medium at 37°C, 5% CO2 overnight. The cells were 
then treated with various concentrations of drug for the intended period of time. 
The medium was removed and 100|al of 10% (v/v) alamarBlue in pRPMI was added 
to each well. The plate was incubated at 37�C，5% CO2 for 2 hours. Plates were 
then read by fluorescence plate reader (Polarion, Tecan) with an excitation at 535nm 
and emission at 590nm. Fluorescence intensity (FI) was then recorded for data 
analysis. 
Statistical Calculations 
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In each experiment, at least three samples were tested in each plate. 
Percentage cytotoxicity was expressed as mean 士 standard deviation (S.D.). The 
percentage cytotoxicity was defined as follows: 
Percentage viability 
=(Mean F.I. of test / Mean F.I. of control) x 100% 
where control cells were treated with complete RPMI medium only. 
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2.2.2 Flow cytometry 
2.2.2.1 Analysis by flow cytometry 
The acquisition of signals from cells was analyzed by "Cell Quest" program 
on the system of FACSort flow cytometer (Becton Dickinson). An argon laser with 
excitation at 488nm was used for the FCM. Prior to the analysis, the forward scatter 
(FSC) that determined the size and side scatter (SSC) that determined the granularity 
of a cell were monitored to determine the population of cells needed for the analysis. 
After the selection of the suitable region of cells, the fluorescence properties of 
10,000 cells were collected. 
After the analysis by FCM, the flow cytometric data was analyzed with the 
software called WinMDI version 2.8 that can be downloaded from internet at 
http://facs.scripps.edu/software.htmL 
2.2.2.2 Determination of Apoptotic and Late Apoptotic/Necrotic Cells with 
Annexin-V-FITC/PI Cytometric Analysis 
HepG2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 150cm^ 
culture flasks and treated with various doses of Polyphyllin D. After treatment, 
both floating and adherent cells were collected. Adherent cells were harvested, 
washed with pRPMI or PBS twice, and 5 x 10^  cells were then loaded with 100 |al of 
incubation buffer containing 2% (v/v) Annexin-V-FITC (Annexin-V) for 20 minutes 
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at room temperature in dark. After that, 400 of incubation buffer containing 
2.5|j,g/ml PI was added and cells were further incubated at room temperature in dark 
for 20 minutes. 
Positive control for this assay was prepared by incubating untreated cells with 
Img/ml of digitonin for 15 minutes. Cells were then stained with Annexin-V and 
PI as mentioned above. Negative control for this assay is prepared by incubating 
untreated cells with 400|il of incubation buffer without any fluorescence staining. 
Analysis was then carried out with a flow cytometer (FACSort, Becton 
Dickinson) with excitation at 488nm and fluorescence signals from Annexin-V-FITC 
and PI were collected respectively at 530nm (green fluorescence) and beyond 650nm 
(red fluorescence) in a logarithm (log) scale. The flow cytometric data was analyzed 
- with WinMDI version 2.8. 
2.2.2.3 Determination of Mitochondrial Membrane Potential (A平m) in cells 
HepG2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 
150cm^ culture flasks and treated with various doses of Polyphyllin D. After 
appropriate treatment, 5 x 10^  cells in 500 pRPMI were loaded with 10 JC-1 
dye (Figure 2.2.2.3.1) at 37°C for 15 minutes. Positive control for this assay was 
prepared by incubating untreated cells with l|iM valinomycin for 15 minutes. Cells 
were then stained with JC-1 as mentioned above. Negative control for this assay is 
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prepared by incubating untreated cells with 500|li1 of pRPMI or PBS without any 
fluorescence staining； Cells were then subjected to flow cytometric analysis with 
excitation at 488 nm. The fluorescence signals from JC-1 were collected at 530nm 
(green fluorescence) and beyond 650nm (red fluorescence) in a logarithm (log) scale. 
Cells in region R1 represent the ones with depolarized mitochondria and was drawn 
with reference to cells treated with valinomycin (the positive control). 
？H3 ？ 
？ ？ 、 
I — C H = C H - I 
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C H . - C H -
• 丄 I I 2 CH3 CH3 
Figure 2.2.2.3.1 Chemical structure of JC-1 (www.probes.com) 
2.2.2.4 Determination of Hydrogen Peroxide (H2O2) Release in cells 
HepG2 (1.5 X \0^/m\) and RHepG2 (2.0 x lOVml) cells were seeded in 150cm^ 
culture flasks and treated with various doses of Polyphyllin D. After treatments, 
cells (5 X 10^) were loaded with 10|iM DCF (Figure 2.2.4.1) and incubated at room 
temperature for 15 minutes. Negative control was prepared by incubating untreated 
cells with 500|J-1 of pRPMI or PBS without any fluorescence staining. Flow 
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cytometry was then carried out with excitation at 488 nm. The fluorescence signals 
from DCF were collected at 530nm (green fluorescence) in a logarithm (log) scale. 
The fluorescence emitted is proportional to the amount of H2O2 release. 
O O II II 
C H 3 — C - O . . ^ T V ^ O •S^X^^IIJI^O - C - C H 3 
I I 1 
"At^ 化一 OH 
II 丁 O 6 — H O - C ‘ ” o 5 
Figure 2.2.2.4.1 Structure of carboxy-HzDCFDA. (www.probes.com) 
2.2.2.5 Measurement of doxorubicin accumulation in cells 
HepG2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 6-well 
plates overnight at 37°C, 5%C02. Cells with or without treatment were incubated 
with various doses of doxorubicin for 3 hours at 37�C，5%C02. Negative control 
was prepared by incubating untreated cells with 500|il o fpRPMI or PBS without 
doxorubicin. After incubation, cells were washed with pRPMI or PBS twice and 
subjected to flow cytometric analysis with excitation at 488nm and emission 
measured beyond 650nm (red fluorescence) in a logarithm (log) scale. 
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2.2.2.6 Determination of P-glycoprotein expression level in cells 
HepG2 (1.5 X lOVml) and RHepG2 (2.0 x 10^/ml) cells were seeded in 6-well 
plates overnight at 37°C, 5% CO2. Cells were then harvested and washed with 
pRPMI or PBS twice. One million cells in 200^1 pRPMI or PBS were stained with 
primary antibody against P-glycoprotein and/or the mouse secondary antibody 
conjugated with FITC. Cells were incubated with the antibodies for 30 minutes 
with occasional mixing. Unbound antibodies were washed with pRPMI or PBS 
twice and then subjected to flow cytometric analysis with excitation at 488nm and 
emission measured with the 530nm (green fluorescence) in a logarithm (log) scale. 
2.2.2.7 Determination of mitochondrial depolarization and swelling in 
isolated mitochondria 
HepG2 and RHepG2 cells were cultured in culture flasks overnight at 37°C, 5% 
CO2. Cells were harvested and washed with pRPMI or PBS twice. Mitochondria 
from cells were isolated according to the method in section 2.2.6. Mitochondria 
(100|j,g/ml) were suspended in mitochondria buffer and incubated with lOOng/ml 
JC-1 at 37°C in dark for 10 minutes. Various doses of Polyphyllin D or 
valinomycin (500nM) was then added and incubated at 37°C in dark for 30 minutes. 
After washing, mitochondria were then subjected to flow cytometric analysis with 
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excitation at 488nm and emission at 530nm (green fluorescence) and beyond 650nm 
(red fluorescence) in a logarithm (log) scale. The FSC readings were recorded and 
represented the size of mitochondria. 
r 
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2.2.3 Methods involved in DNA sequencing of MDRl promoter 
2.2.3.1 DNA extraction 
HepG2 and RHepG2 cells were harvested from culture flasks, washed twice 
with pRPMI / PBS. One million cells were then re-suspended in 500|j.l DNA lysis 
buffer and incubated at 37°C overnight. DNA was extracted by adding 0.5 ml 
phenol and 0.5 ml chloroformdsoamyl alcohol (24:1) and spun by centrifuge (MSE, 
MicroCentaur, Sanyo) at 10,000 rpm for 1 minute. After centrifugation, the 
aqueous layer was extracted, mixed with 1ml chloroform:isoamyl alcohol and 
centrifuged at 10,000 rpm for 1 minute. The upper phase was transferred to a new 
microcentrifuge tube. Samples were mixed with 46\x\ of 5M ice-cold NaCl and 1ml 
of absolute ice-cold ethanol. Samples were then stored at -20°C overnight. Mixture 
r 
was spun at 14,000 rpm at 4°C by centrifugation for 20 minutes. Ethanol was 
drained away and DNA pellet was air-dried overnight. Twenty micro-liters of TE 
buffer with RNase A (20fj,g) was added to each tube and incubated at 3 TC for 2 
hours. Samples were stored at 一 2 0 � C until use. Multiple freeze-thaw cycles were 
avoided. . 
2.2.3.2 DNA and Gel Band Purification 
Extracted genomic DNA or gel band w ere purified with the GFX PGR DNA 
and Gel Band Purification Kit (Amersham Biosciences) according to instructions 
enclosed. 
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2.2.3.3 Assessment of DNA amount 
The DNA content was measured by reading O.D. at 260nm and 280nm under a 
UV-visible spectrophotometer (Shimadzu, model UV-1601). Two |il of DNA sample 
in 0.5 ml dH20 was used for O.D. determination. Amount of DNA (|ig/fil) in 
samples was (O.D.260 / 0.1) x (5 / 1000) x (502 / 2). ‘ 
2.2.3.4 Polymerase Chain Reaction 
The use of PGR to amplify the sequence wanted, a reaction mixture was 
prepared and incubated in a thermocycler for 30 cycles. A 25fj.l PCR reaction 
mixture was prepared with 5|j,l 5X PCR buffer (supplied with the Taq polymerase in 
‘ use). Then, 12.25|al of autoclaved dH20, dNTP 0.5nl (final 200)aM), 5\x\ of DNA 
template (around l|ag), and \[i\ each of forward and reverse primers (final conc. 
2|j,M) were added. Finally, 0.25|j,l Taq polymerase (final 1.25U) was added and the 
mixture was mixed and quickly incubated in the thermocycler for PCR reaction. 
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Table 2.2.3.4.1 Condition for PCR for the amplification of MDRl promoter 
Conditions Temperature Time Number of Cycles 
Initial denaturation 95°C 3 min J 
950� 45 sec 30 cycles according 
Denaturation to different genes 
Annealing 60"C 30 sec 
Elongation 1 min 30 sec 
Final Elongation 72�C 10 min I 
Table 2.2.3.4.2. Primers for amplification of MDRl promoter in HepG2 and 
RHepG2 cells by PCR. 
Primer Sequence 
MDRIPRO-For . CAT CCT CAG ACT ATG CAG 
MDRl PRO Rev AGC CAG AG A GCA GTAAGA 
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2.2.3.5 Agarose Gel Electrophoresis 
One percent of agarose gel was prepared by dissolving the agarose powder in 
IX TBE buffer in the flask. The flask was then weighed and was put into the 
microwave oven to heat for 1 min until the agarose dissolved. The mixture was then 
cooled to around 50°C and was poured into the cassette until the agarose formed the 
gel like structure. Before electrophoresis, all of the PGR products were mixed with 
6X DNA loading buffer and then run in agarose gel for constant voltage. After that, 
the gel was stained with ethidium bromide for 15 minutes and then put onto the UV / 
White light transilluminator (Spectroline, model TVD-IOOOR). Under UV 
illumination, the gel bands of appropriate size (around 1.5kbp) were cut quickly to 
avoid mutation. The DNA in the band was then extracted with GFX PCR DNA and 
Gel Band Purification Kit (Amersham Biosciences) as previously described. 
2.2.3.6 Preparation for DNA sequencing 
For each sequencing reaction, 80ng of PCR product was dissolved in dH20 and 
submitted for DNA sequencing. For each promoter sequence, three primers were 
used for DNA sequencing to ensure the whole promoter was sequenced. The 
primers .used for sequencing is listed in Table 2.2.3.6.1 • 
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Table 2.2.3.6.1 Primers for sequencing of MDRl promoter 
Primer Sequence 
MDRIPRO-For CAT CCT CAG ACT ATG CAG 
MDRIPRO 671 GGT GTT AGG AAG CAG AAA GGT G 
MDRl PRO Rev AGC CAG AG A GCA GTAAGA 
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2.2.4 Western Blotting Analysis 
2.2.4.1 Preparation of Proteins from Cells 
Total Protein Extraction 
Treated cells were harvested and washed with pRPMI / PBS twice and the 
number of cells was then counted. For one million of cells, 100 |il of lysis buffer 
(1% (w/v) SDS, ImM Na3V04, lOmM Tris, 5mM MgCh, 21|dg/ml aprotinin, 5|ig/ml 
leupeptin, ImM PMSF and pH == 7.4) was added and incubated at room temperature 
for 30 minutes. After that, samples were boiled for 10 minutes and centrifugation at 
20,812 X g (14,000 rpm, 9.5cm, Eppendorf Centrifuge 5417R) for 7 minutes at 4�C. 
Supernatant was then collected and stored at -20°C. 
Determination of Protein Amount 
The amount of protein obtained by SDS lysis method was examined by BCA 
assay. The assay was carried out in a 96-well plate. First of all, the protein standards 
with different amounts of bovine serum albumin (BSA, with 2, 4’ 6, 8, lO^ig per well) 
were added to each well. For the part of protein samples, l^il of protein samples were 
mixed with 9[i\ of PBS in each well. Three replicate of samples and BSA standard 
were performed. After that, 200|al of BCA mixture consisting of BCA (bicinchoninic 
acid) solution and CuSCU • 5H2O solution in a ratio of 50:1 was added to each well 
and the plate was then incubated at 37°C for 30 minutes. The absorbance was then 
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recorded at 540nm with a microplate reader, using BCA mixture containing PBS 
solely as a blank. The standard curve was then plotted with the x-axis represented the 
concentration of BSA and the y-axis represented the absorbance at 540nm measured. 
The equation was developed from the standard curve and it was then used for the 
determination of the amount of protein. 
Cytosolic Protein Isolation 
Cytosolic protein can be isolated with the use of digitonin at various 
concentrations. Cells with appropriate treatments were harvested and washed with 
pRPMI / PBS twice. The number of cells was then counted. In each sample, 50|il of 
lysis buffer (75mM NaCl, ImM NaHzPCU，8mM NazHPC^，250mM sucrose, 
„ 21|ig/ml aprotinin, 5|ig/ml leupeptin, ImM PMSF and various concentrations of 
digitonin) was added to 4 million of cells and the mixture was vortex vigorously for 
30 seconds at room temperature. After that, samples were spun at 10,621 x g (10,000 
rpm, 9.5cm, Eppendorf Centrifuge 5417R) for 1 minute at room temperature with a 
centrifuge (MSB, MicroCentaur, Sanyo). Subsequently, supernatant was then 
collected and 50 [i\ of 2X SDS loading buffer was added. The mixture was then 
boiled for 10 minutes and centrifugation was then carried out at 20,817 x g (14,000 
rpm, 9.5cm, Eppendorf Centrifuge 5417R) at 4°C for 7 minutes. After that, 
supernatant was collected and the extract was stored at -20°C. 
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2.2.4.2 Preparation of proteins from isolated mitochondria 
HepG2 and RHepG2 cells were cultured in culture flasks overnight at 37°C, 
5% CO2. Cells were harvested and washed with pRPMI or PBS twice. 
Mitochondria from cells were isolated according to the method mentioned in section 
2.2.6. Mitochondria (100|ig/ml) were suspended in mitochondria buffer. Various 
doses of Polyphyllin D or antimycin A (3.8iliM) was then added and incubated at 
37°C for 3 hours. After that, mitochondria were pelleted by centrifugation at 
12000g for 3 minutes at 4°C. The resulting supematants were concentrated with the 
YM-10 filter (Microcon; Amicon, Millipore, USA). Protein on the filter was eluted 
with dHzO and lyophilized. The resulting powder containing the released protein 
from the isolated mitochondria were resuspended with dH20, aliquoted, and mixed 
‘ with 2X SDS loading buffer for analysis with SDS-PAGE. 
2.2.4.3 Protein analysis with Western analysis 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The apparatus of Mini-Protean II cell (BIO-RAD Laboratories) for 
SDS-PAGE was set up according to the manual. 
12% SDS polyacrylamide separating gel and 4.5% stacking gel were used. In 
each experiment, 25 jag of protein samples was mixed with equal volume of 2X SDS 
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loading buffer and samples were then boiled for 3 minutes. Then, protein samples, 
together with the-low range protein marker were loaded on each well. The voltage 
was set at 150V and protein samples were run for 1 hour. After that, gels were 
removed from the apparatus and were soaked in electroblot buffer. 
Electroblotting of Protein 
The electroblotting of proteins was carried out with the use of the Mini 
Trans-Blot Cell (tank transfer system, BIO-RAD Laboratories). 
Prior to the electroblotting, the dry 0.22|im PVDF (polyvinylidene fluoride) 
membrane (Immobilon-pSQ, Millipore) was rehydrated with absolute methanol and 
‘ then immersed in electroblot buffer. Moreover, 1mm filter paper (Whatman) was 
also soaked in electroblot buffer before use. The tank transfer system for 
electroblotting was set up with the following sequence: cathode, fiber pad, 3X filter 
paper, gel, PVDF membrane, 3X filter paper, fiber pad, anode. Electroblotting was 
then performed with the voltage of 100 V for 1 hour. 
Probing Antibodies for Proteins 
After blotting, the membrane was transferred to a petri dish and 20ml of 5% 
non-fat milk (in TBS-T) was added for non-specific blocking. The membrane was 
incubated at room temperature for 2 hours and then probed with primary antibody 
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diluted in non-fat milk (in TBS-T) and stored at 4°C overnight. After that, the 
antibodies were removed and the membrane was washed with TBS-T three times for 
15 minutes. Secondary antibody was then loaded to the membrane for another hour. 
After that, the membrane was washed with TBS-T twice for 15 minutes and then 
subjected to the enhanced chemiluminescence assay. 
Enhanced Chemiluminescence (ECL) Assay 
ECL assay was performed by mixing the ECL reagent 1 and reagent 2 in a 
ratio of 1:1 (Amersham Pharmacia Biotech). The membrane was then exposed to the 
ECL reagent mixture for 1 minute at room temperature. After that, the m embrane 
was preserved between two layers of transparency and was developed on Fuji 
f t 
Medical x-ray film (super Rx, Fuji) at various time periods. Films were then 
processed in a film processor (M35 X-OMAT, Kodak). 
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2.2.5 Confocal laser scanning microscopy (Confocal microscopy) 
2.2.5.1 Analysis with confocal microscopy 
Cells were observed on a system of confocal microscopy (Multiprobe 2001, 
Molecular Dynamics) fitted with an argon laser (6mW at excitation) and Nikon 
diaphot inverted microscope. For fluorescence determination by confocal 
microscopy, an excitation filter with 4 88nm wavelength and a long-pass emission 
filter of 51 Onm were used. Cells were scanned by using a 40X (Nikon PlanApo) air 
objective, or 60X (Nikon PlanApo) oil objective with low-fluorescence immersion 
, oil (77 230c = 1,515，Stephens Scientifics, USA). The voltage of the PMT was set at 
optimum. Images and fluorescence intensities were processed and averaged by 
image analysis software (Imagespace 3.2). 
2.2.5.2 Detection of mitochondrial changes in cells by confocal microscopy 
‘ HepG2 and RHepG2 cells (5 x 10^) were seeded in glass coverslips overnight 
at 37°C, 5% CO2. Cells were treated with or without Polyphyllin D (2.5|iM) for 21 
hours at 37°C, 5% CO2. During the last 3 hours of incubation, cells were collected 
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and stained with 10|LIM JC-1 and then subjected to confocal microscopy analysis. 
2.2.5.3 Detection of lysosomal rupture in cells by confocal microscopy 
HepG2 and RHepG2 cells (5 x 10 )^ were seeded in glass coverslips overnight 
at 37°C, 5% CO2. Cells were treated with or without Polyphyllin D (2.5nM) and 
then incubated for 21 hours at 37�C，5% CO2. During the last 3 hours of incubation, 
cells were collected and stained with 16ng/ml AO, and then subjected to confocal 
microscopy analysis. 
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2.2.6 Mitochondrial isolation 
HepG2 or RHepG2 cells were collected from culture flasks, washed with PBS 
for 2 t imes, a nd t hen r esuspended i n C ytosol E xtraction b uffer (supplied w ith t he 
Mitochondria/Cytosol Fractionation Kit purchased from Bio Vision) on ice for 30 
minutes. After that, cell suspension was added to Dounce homogenizer and 
homogenized with 30 strokes on ice. The cell lysate was then centrifuged at 700g 
for 10 minutes to pellet the nucleus and cell debris. The resulting supernatant was 
centrifuged at 12，000g for 3 minutes to pellet the mitochondria. The mitochondria 
pellet was resuspended in mitochondria buffer and centrifuged at 12,000g for 3 
minutes. The mitochondria pellet was then resuspended in the same buffer for 
further analysis. Mitochondria were kept in ice during the whole process. 
r 
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There are a number of cellular changes that contribute to MDR. The 
differences between the parental HepG2 and the multi-drug resistant RHepG2 cells 
were examined. ^ 
3.1 Resistance of RHepG2 cells towards various chemical agents 
As mentioned in the 'Introduction', MDR often associates with the resistance 
in cells in terms of cytotoxicity towards a number of chemical agents that are 
structurally and functionally unlike. Therefore, the response of RHepG2 cells 
towards a number of chemical agents was investigated. 
3.1.1 RHepG2 cells are resistant to doxorubicin 
The effect of doxorubicin on cytotoxicity in HepG2 and RHepG2 cells were 
investigated first. Doxorubicin is a commonly used anti-cancer drug targeting the 
topoisomerase II enzyme in cells. HepG2 and RHepG2 cells were treated with 
various doses of doxorubicin for 24 hours. After that, cell viability was 
determined by alamarBlue as mentioned in Materials and Methods. 
As shown in Figure 3.1.1.1, there is a dose-dependent decrease in cell viability 
in both doxorubicin treated HepG2 and RHepG2 cells. Moreover, it was found 
that RHepG2 cells were much more resistant to doxorubicin. Whereas 80|iM 
doxorubicin caused about 50% cytotoxicity in HepG2 cells, the same treatment only 
caused 30% cytotoxicity in RHepG2 cells (Figure 3.1.1.1). 
Chapter 3 Results 一 Resistance Mechanisms in RHepG2 Cells 
Page 71 
Cytotoxicity of Doxorubicin in HepG2 cells 
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� F i g u r e 3.1.1.1 Effect of doxorubicin on cytotoxicity in HepG2 and RHepG2 
cells. HepG2 (1.5 x lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 
96-well plates overnight at 37�C，5% CO2. Various concentrations of 
doxorubicin in medium were added and cells were then incubated for 24 hours at 
37®C, 5% CO2. After incubation, cytotoxicity assay was carried out with 
alamarBlue as mentioned in Materials and Methods. Results are mean 士 SD for 
at least 6 determinations. Representative results were shown from triplicate 
experiments with essential similar results. 
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3.1.2 RHepG2 cells are resistant to taxol 
The response of RHepG2 cells towards another chemotherapeutic agent, taxol 
was examined. Taxol is an anticancer drug which stabilizes the assembled 
microtubules in cells, leading to the disruption of equilibrium between tubulin and 
microtubules and thus causing apoptosis in cells (Ganesh et al., 2004). HepG2 and 
RHepG2 cells were treated with various doses of taxol for 24 hours. After that, 
cell viability was determined by alamarBlue. 
As shown in Figure 3,1.2.1, there is a dose-dependent decrease in cell viability 
in both HepG2 and RHepG2 cells treated with taxol. However, the cytotoxicity of 
taxol was much higher in HepG2 than that in RHepG2 cells. Fifty micromolar of 
taxol caused about 36% HepG2 cell cytotoxicity, but the same dose of drug caused 
only about 20% cytotoxicity in RHepG2 cells. 
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Cytotoxicity of Taxol in HepG2 cells 
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Figure 3.1.2.1 Effect of taxol on cytotoxicity in HepG2 and RHepG2 cells. 
HepG2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in 96-well 
plates overnight at 37�C, 5% CO2. Various concentrations of taxol in medium 
were added and cells were then incubated for 24 hours at 37°C, 5% CO2. After 
incubation, cytotoxicity assay w as carried out with alamarBlue as mentioned in 
Materials and Methods. Results are mean 士 SD for at least 6 determinations. 
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3.1.3 RHepG2 cells are resistant to valinomycin 
Beside chemotherapeutic agents, response of RHepG2 cells towards 
valinomycin, a potassium ionophore, was also investigated. Valinomycin acts on the 
mitochondria in cells and causes mitochondrial membrane depolarization by 
increasing the potassium conductivity of mitochondrial membrane (Inai et al., 1997). 
HepG2 and RHepG2 cells were treated with 1|LIM of valinomycin and then 
stained with the mitochondrial-specific dye JC-1. JC-1 is a cationic dye which 
exhibits voltage-dependent accumulation in the mitochondria. JC-1 forms 
aggregates in mitochondria with high mitochondrial potential and emits red 
fluorescence when excited. In low mitochondrial potential, JC-1 becomes 
monomers and gives green fluorescence when excited (www.probes.com). 
As shown in Figure 3.1.3.1，the number of RHepG2 cells with stronger green 
fluorescence (63.2%) was 1 ess than that o fHepG2 cells (79.1%) after valinomycin 
treatment suggesting that RHepG2 cells are resistant to the valinomycin-induced 
mitochondrial depolarization. 
V 
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Figure 3 . 1 . 3 . 1 Valinomycin-induced mitochondrial membrane 
depolarization in HepG2 and RHepG2 cells. HepG2 (1.5 x loVml) and 
RHepG2 (2.0 x lOVml) cells were seeded in 100mm culture dishes overnight at 
‘3TC, 5% C02. Cells were then treated with or without valinomycin (1|liM) at 
37°C, 5% CO2 for 15 min. For the control, HepG2 cells (a) or RHepG2 cells (c) 
were incubated with medium only. In the test group, HepG2 cells (b) or 
RHepG2 cells (d) were incubated with l | iM valinomycin for 15 minutes. After 
that, cells were collected and stained with JC-1 dye and then subjected to flow 
cytometric analysis at 53Onm (FL-1 channel) and beyond 650 nm (FL-3 channel). 
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3.2 Resistance mechanisms in RHepG2 cells 
Having known that RHepG2 cells were more resistant to the cytotoxic activity 
of doxorubicin and other chemical agents, we subsequently investigated the possible 
mechanisms that may cause this resistance. 
3.2.1 Reduced doxorubicin accumulation is observed in RHepG2 cells 
To elicit its cytotoxic effect, a chemical may e ither interact with e xtracellular 
receptors or enter the cells to influence target organelles or proteins. Since 
doxorubicin, taxol and valinomycin acts on different intracellular components, one 
common resistance mechanism which causes resistance to these chemicals may work 
by preventing their accumulation in cells. Since doxorubicin is intrinsically 
fluorescent, the accumulation of doxorubicin in cells can be directly measured by the 
doxorubicin's fluorescence emission at 590nm. This provides a convenient means 
for us to monitor the amount of doxorubicin in cells. 
HepG2 and RHepG2 cells were seeded overnight and incubated with various 
concentrations of doxorubicin for 3 hours. The cells were then collected for flow 
cytometric analysis beyond 650nm (FL-3 channel). 
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Figure 3.2,1.1 Doxorubicin accumulation in HepG2 cells. HepG2 (1.5 x 
10 /ml) cells were seeded in a 6-well plate overnight at 37®C, 5% CO2. Various 
concentrations of doxorubicin was added and incubated for 3 hours at 37�C, 5% 
‘ C 0 2 . After that, cells were collected and subjected to flow cytometric analysis 
beyond 650nm (FL-3 channel). Panels (a-f) represent HepG2 cells incubated 
with 0|iM, 0.25fj,M, 0.5|aM, l|iM, 2|iM and doxorubicin respectively. 
Representative results were shown from duplicate experiments with essential 
similar results. 
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Figure 3.2.1.2 Doxorubicin accumulation in RHepG2 cells. RHepG2 (2.0 x 
10 /ml) cells were seeded in a 6-well plate overnight at 37�C, 5% CO2. Various 
concentrations of doxorubicin was added and incubated for 3 hours at 37°C, 5% 
CO2. After that, cells were collected and subjected to flow cytometric analysis 
beyond 650nm (FL-3 channel), (a) RHepG2 cells incubated with medium only, 
(b) RHepG2 cells incubated with 4fiM doxorubicin. Representative results were 
shown from duplicate experiments with essential similar results. 
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From Figures 3.2.1.1 and 3.2.1.2，we can see that there is more doxorubicin 
accumulated in both HepG2 and RHepG2 cells when doxorubicin concentration was 
increased. However, whereas doxorubicin accumulation in HepG2 cells increased 
significantly with 4|j,M of doxorubicin in the buffer, the increase in doxorubicin 
accumulation in RHepG2 cells was more reluctant with the same concentration of 
doxorubicin. Therefore, the accumulation of doxorubicin in RHepG2 cells was 
hindered by certain cellular mechanism and this mechanism may account for the 
doxorubicin resistant properties in RHepG2 cells. 
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3.2.2 More P-glycoproteins on the cell surface were observed in RHepG2 cells 
From literature, we found that doxorubicin is a substrate of P-glycoprotein. 
P-glycoprotein is an ATP-binding protein which actively pumps the anticancer agents 
out of the cells (Ambudkar et al., 1999). So, the reduced doxorubicin accumulation 
may be due to an enhanced removal of doxorubicin from cells. 
We therefore investigated whether there is an up-regulation of P-glycoprotein 
expression in RHepG2 cells. In this study, HepG2 and RHepG2 cells were 
incubated with anti-P-glycoprotein antibody and then subjected to flow cytometry 
analysis. As shown in Figure 3.2.2.1，RHepG2 cells had a much higher level of 
P-glycoprotein expression than that of HepG2 cells. Yet, no significant difference 
was observed when both cell lines were treated with the FITC-conjugated secondary 
antibody only. This suggests that more P-glycoproteins were found on the cell 
membrane of RHepG2 cells when compared to that of HepG2 cells. Thus, it is 
possible that the reduced doxorubicin accumulation in RHepG2 cells was due to an 
enhanced P-glycoprotein expression in RHepG2 cells. 
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Figure 3.2.2.1 P-glycoprotein expression in HepG2 and RHepG2 cells. � H e p G 2 (1.5 X lOVml) and RHepG2 (2.0 x lOVml) cells were seeded in culture 
flasks overnight at 37°C, 5% CO2. Cells were collected and incubated with or 
without anti-P-glycoprotein antibody (1�antibody) for 30 minutes at 37®C. After 
washing, cells were treated with mouse-FITC antibody (2�antibody). Cells were 
washed again and subjected to flow cytometric analysis at 530nm (FL-1 channel). 
Representative results were shown from triplicate experiments with essential 
similar results. 
Chapter 3 Results - Resistance Mechanisms in RHepGl Cells Page 82 
3.2.3 Inhibition of P-glycoprotein activity increased doxorubicin 
accumulation in RHepG2 cells 
To confirm the effects of P-glycoprotein on doxorubicin accumulation in 
RHepG2 cells, the P-glycoprotein inhibitor verapamil was used (Verschraagen et al 
1999). HepG2 and RHepG2 cells were pretreated with verapamil (lOO^iM) at 37°C 
for 2 hours. After that, doxorubicin was added and cells were incubated for 3 hours 
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Figure 3.2.3.1 Graphic representations of RHepG2 treatments. 
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• (d) Verapamil 99.15% Doxorubicin + doxorubicin Fluorescence Figure 3.2.3.2 Doxorubicin accumulation in RHepG2 cells with or without 
verapamil pre-treatment. RHepG2 (2.0 x lOVml) cells were seeded in 6-well 
plates overnight at 3TC, 5% CO2 and then treated with various agents as shown in 
Figure 3.2.3.1 • For all treatments, cells were incubated at 37®C, 5% CO2. After 
that, cells were collected and subjected to flow cytometric analysis beyond 650nm 
(FL-3 channel), (a) RHepG2 cells incubated with medium only, (b) RHepG2 
cells treated with lOOjiM of verapamil for 5 hours, (c) RHepG2 cells incubated 
with 4|iM doxorubicin for 3 hours, (d) RHepG2 cells pretreated with lOO^M 
verapamil for 2 hours, and then 4|LIM doxorubicin was added and cells were 
incubated for 3 hours further. Representative results were shown from duplicate 
experiments with essential similar results. 
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As shown in Figure 3.2.3.2, the addition of verapamil enhanced doxorubicin 
accumulation in RHepG2 cells. When the responses of cells with or without 
verapamil pre-treatment were compared (Figures 3.2.3.2 c and d), it can be seen that 
42.94% of RHepG2 cells had enhanced doxorubicin accumulation in cells with 
lOOjaM verapamil pre-treatment. This difference was much higher than that elicited 
by verapamil (Figure 3.2.3.2b). Taken together, P-glycoprotein was expressed in 
RHepG2 cells which contributed to the resistance of RHepG2 cells to doxorubicin. 
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3.2.4 HepG2 and RHepG2 cells contain the same P-glycoprotein promoter 
region 
In view of the enhanced P-glycoprotein in RHepG2 cells, we wonder if it is 
caused by mutations in the promoter region of the MDRl gene, the gene that codes for 
P-glycoprotein. DNA from HepG2 and RHepG2 cells were extracted. Since most 
tissues and cell lines including HepG2 cells mainly uses the downstream MDRl 
promoter (Ueda et a /.，1 987b), p rimers t hat frank t he d ownstream p remoter r egion 
were designed and the isolated DNA was amplified with these primers. The 
polymerase chain reaction (PCR) product was about 1.6kb, which contains both the 
major and minor transcription initiation sites of the downstream MDRl promoter 
(Ueda et al., 1987a). To ensure the primers will not frank other similar sequences, 
they were searched for similar sequences with the blast engine available at 
http://www.ncbi.nlm.nih.gov/BLAST/. Results of searching indicate that the primers 
are specific for the downstream MDRl promoter. 
After PCR, PCR products were submitted for DNA sequencing. For each 
sample, PCR products from different runs were submitted for sequencing to eliminate 
errors arose from DNA sequencing or PCR. In Figure 3.2.4.1, the promoter region 
of HepG2 and RHepG2 cells were aligned with the MDRl promoter sequence of the 
human leukocyte reported to gene bank (Accession number L07624). As can be 
seen from the Figure, the three sequences were the same except there are two 
unsequenced nucleotides in positions 46 and 56 of our sequence. The identity 
between the HepG2/RHepG2 promoter sequences with the human leukocyte promoter 
indicates that the PCR with the primers we employed amplified the downstream 
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MDRl promoter region of HepG2 and RHepG2 genome. The unsequenced positions 
in our sequence may be deletion mutations that exist intrinsically in HepG2 cells. 
Since it was away from the transcription initiation sites and the reported downstream 
MDRl promoter region (Ueda et al., 1987b), the deletion should not be related to the 
MDRl promoter function. As the promoter sequence from HepG2 and RHepG2 
cells were completely identical, the enhanced P-glycoprotein expression in .RHepG2 
cells was not likely to be due to mutation in the downstream promoter region. 
Therefore, other factors such as gene amplification or variations in transcription 
factors in RHepG2 cells may account for the over-expression of P-glycoprotein. 
f*r 
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HepG2 1 
RHepG2 ( - 1 6 8 1 ) 
L07624 - CATV CTCAGACTAT GCAGTAAAAA 
i i 
25 TTTCTTCTTC T-AACTTATG C-ATAAACTG ATAGGTAATA TGTGAAAGTC 
( - 1 6 5 7 ) u t c t l c t t c t - a a c U a t g c - a l a a a c t g a l a g g l a a t a i g t g a a a g l c 
ACAAAGTGAT TTTCTTCTTC TAAACTTATG CAATAAACTG ATAGGTAATA TGTGAAAGTC 
85 ATAGAATGTA GACTAGAGGA TACAACAAAC CTATITCCTC TATGTTCATA AGAAGTAAGA 
( - 1 5 9 7 ) a t a g a a t g t a g a c l a g a g g a l a c a a c a a a c c t a l t t c c t c t a t g l t c a t a a g a a g t a a g a 
ATAGAATGTA GACTAGAGGA TACAACAAAC CTATTTCCTC TATUTTCATA AGAAGTAAGA 
145 AAAGCTCTGA TGTGAGTTAG CATTGCnTA CAATTTTGAA TTGTGCAGAT TGCACGTACT 
( - 1 5 3 7 ) a a a g c l c t g a t g t g a g t l a g c a l t g c t l l a c a a t l t t g a a t t g t g c a g a t t g c a c g t a c t 
AAAGCTCTGA TGTGAGTTAG CATTGCJITA CAATTTTGAA TTGTGCAGAT TGCACGTACT 
205 TTTCCTCAGT TTGAAGTAAA TAGTGGACAG GAAAAAATAT TAAATGTTGG CAGTAAATAT 
- ( - 1 4 7 7 ) 1 1 t c c t c a g t t l g a a g t a a a l a g t g g a c a g g a a a a a a l a t t a a a l g l t g g c a g l a a a l a l 
TTTCCTCAGT TTGAAGTAAA TAGTGGACAG GAAAAAATAT TAAATGTTGG CAGTAAATAT 
265 GGAAGGAAAT TACAACTAAT GTAATATGCT AAAACATGCT ATGnTATTT TACTAATTTG 
( - 1 4 1 7 ) ggaaggaaa t l a c a a c l a a t g t a a t a t g c t a a a a c a t g c t a t g l l l a l l t l a c t a a t t t g 
GGAAGGAAAT TACMO'MT (TTMTATWT AmCATGCT ATUmATTT TACTAATTTG 
325 AATTAAAATG TAAGAATTTA AAATGCCCTG GAAAAACACG GGCATTGATC TGACGTCTGA 
( - 1 3 5 7 ) a a t t a a a a t g l a a g a a l I l a a a a l g c c c t g g a a a a a c a c g g g c a l t g a t c t g a c g t c t g a 
AATTAAAATG TAAGAATTTA AAATGCCCTG GAAAAACACG GGCATTGATC TGACGTCTGA 
385 AGTnTAAAA TATTACACAC TTTGAAATAG CATTTGTACC TTGAAATACC TGTCTCTATA 
( - 1 2 9 7 ) a g t t t t a a a a t a t t a c a c a c I t l g a a a l a g c a t t t g t a c c t t g a a a l a c c t g t c t c t a t a 
� AGTnTAAAA TATTACACAC TTTGAAATAG CAnTGTACC TTGAAATACC TGTCTCTATA 
445 TATTmTAA MCTTCCTTT TTCTTTCATr CCATTTATCA TCAAATAAAG GATGAACAGA 
( - 1 2 3 7 ) t a t t t t t t a a a a c t l c c l l l l l c t t t c a l t c c a t t t a l c a t c a a a l a a a g g a l g a a c a g a 
TATrmTAA AACTTCCTU TTCnTCATT CCATTTATCA TCAAATAAAG GATGAACAGA 
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505 TGTAACTCAG AAACTGTCAA GCATGCTGAA GAAAGACCAC TGCAGAAAAA TTTCTCCTAG 
( - 1 1 7 7 ) t g t a a c t c a g a a a c t g t c a a g c a l g c t g a a gaaagaccac t gcagaaaaa t I t c t c c t a g 
TUTAACITAG AAAOUTTAA GCATGCTGAA GAAAGACCAC TGCAGAAAAA TTTCrCCTAG 
565 CCmrCAAA GGTGTTAGGA AGCAGAAAGG TGATACAGAA TTGGAGAGGT CGGAGTmT 
( - 1 1 1 7 ) c c t t t t c a a a g g t g t t a g g a agcagaaagg i g a l a c a g a a t t g g a g a g g t c g g a g t t t t t 
CCTUTCAAA GGTGTTAGGA AGCAGAAAGG TGATACAGAA TTGGAGAGGT CGGAGTmT 
625 GTATTAACTG TATTAAATGC GAATCCCGAG AAAATTTCCC TTAACTACGT- CCTGTAGTTA 
( - 1 0 5 7 ) g t a t t a a c t g l a t l a a a t g c g a a t c c c g a g a a a a l t l c c c t l a a c t a c g t c c t g t a g t t a 
GTATTAACTG TATTAAATGC GAATCCCGAG AAAATTTCCC TTAACTACGT CCrGTAGTTA 
685 TATGGATATG AAGACTTATG TGAACHTGA AAGACGTGTC TACATAAGTT GAAATGTCCC 
( - 9 9 7 ) l a t g g a t a t g a a g a c t t a t g I g a a c l l i g a a a g a c g l g t c t a c a l a a g t t g a a a t g t c c c 
TATGGATATG AAGACTTATG TOAACTTTGA AAGACGTGTC TACATAAGTT GAAATUTCCC 
745 CAATGATTCA GCTGATGCGC GTITCTCTAC rTGCCCTTTC TAGAGAGGTG CAACGGAAGC 
( - 9 3 7 ) c a a t g a t t c a g c t g a t g c g c g l t l c t c t a c t l g c c c t t t c t a g a g a g g t g caacggaagc 
CAATGATTCA GCTGATGCGC GTTTCTCTAC TTGCCCnTC TAGAGAGGTG CAACX]GAAGC 
f 
805 CAGAACATTC CTCCTGGAAA TTCAACCTGT TTCGCAGnT CTOAGGAAT CAGCATTCAG 
. ( - 8 7 7 ) c a g a a c a t t c c t c c t g g a a a i t c a a c c t g t t t c g c a g t t l c t c g a g g a a t c a g c a t t c a g 
CAGAACATTC CTCCTGGAAA TTCAACCrCT TTOGCAGTU CTCGAGGAAT CAGCATTCAG 
865 TCAATCCGGG CCGGGAGCAG TCATCTGTGG TGAGGCTGAT TGGCTGGGCA GGAACAGCGC 
( - 8 1 7 ) t c a a t c c g g g ccgggagcag t c a t c t g t g g t g a g g c t g a t t g g c t g g g c a ggaacagcgc 
TCAATCCGGG CCGGGAGCAG TCATCTGTGG TGAGGCTGAT TGGCTGGGCA GGAACAGCGC 
925 CGGGGCGTGG GCTGAGCACA GCOGCTTCGC TOTTTTGCC ACAGGAAGCC TGAGCTCATT 
( - 7 5 7 ) cggggcgtgg g c t g a g c a c a g c c g c t l c g c i c t c t t t g c c acaggaagcc t g a g c t c a t l 
-CGGGGCGTGG GCTGAGCACA GCCGCTTCGC TCIUITTGCC ACAGGAAGCC WAGCITATT 
985 CGAGTAGCGG CrOTCCAAG CTCAAAGAAG CAGAGGCCGC TGTrcGTTTC CnTAGCrTCT 
( - 6 9 7 ) c g a g l a g c g g c t c t t c c a a g c t c a a a g a a g cagaggccgc t g l l c g l l t c c l t t a g g t c t 
CGAGTAGCW CTCTTCCAAG CTCAAAGAAG CAGAGGOJGC TGTTCGnTC CnTAGGTUT 
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1045 TTCCACTAAA GTCGGAGTAT CITCTTCCAA GATTTCACGT CTTGGTGGCC GTTCCAAGGA 
( - 6 3 7 ) t t c c a c t a a a g t c g g a g l a t c l l c t t c c a a g a l t t c a c g l c t t g g t g g c c g t l c c a a g g a 
nrCACTAAA GimAGTAT CnOTCCM GATTTCACGT CnWTGGCC GTTCCAAGGA 
1105 GCGCGAGGTA GGGGCACGCA MGCTGGGAG CTACTATGGG ACAGTTCCCA AGTGTCAGGC 
( - 5 7 7 ) gcgcgagg ta ggggcacgca aagc lgggag c l a c t a l g g g a c a g l t c c c a a g t g t c a g g c 
GCGCGAGGTA GGGGCACGCA AAGCTCiGGAG mCTATGGG ACAGTTCCCA AGTGTCAGGC 
1165 TTTCAGATTT CCTGAACTTG GTCTTCACGG GAGAAGGGCT TCTTGAGGCG TGGATAGTGT 
( - 5 1 7 ) t t l c a g a t l t c c t g a a c t l g g l c l l c a c g g gagaagggc t i c t l g a g g c g t g g a t a g t g l 
TTTCAGAm CCTGAACTTG GTCTTCACGG GAGAAGGGCT TCTTGAGGCG TGGATAGTGT 
1225 GAAGTCCrcr GGCAAGTCCA TGGGGACCAA GTGGGGTTAG ATCT 
( - 4 5 7 ) g a a g t c c t c t g g c a a g t c c a tggggaccaa g t g g g g t t a g a i d 
GAAGTCCTCr GGCAAGTCCA TCKKKJACCAA GTGGGGTTAG A TCTAGACTC AGGAGCTCCT 
1525 
( - 1 5 7 ) 
- CAGTGCCCAT CGCGGCCAGA GCAGCTGGGG CATCAACGGC GGGCJGCTCCC TpTACTGCT 
. 1 5 8 5 
( - 9 7 ) 
CTCTGGCT < 
Figure 3.2.4.1 Sequencing results of HepG2 and RHepGl MDRl promoter. 
Genomic DNA from HepG2 and RHepG2 cells were extracted. PGR was performed 
and the product was subjected to DNA sequencing. The sequencing results were aligned 
with the MDRl promoter sequence of the human leukocyte reported to gene bank 
(Accession number L07624) (sequence in green). Sequences in blue and pink represent 
sequencing results of HepG2 and RHepG2 MDRl promoter regions respectively. 
Regions marked with horizontal arrows represent regions primed with primers. 
Positions marked with vertical arrows are positions not matched to L07624. The 
numbers not in parentheses represent the nucleotides numbered from the first nucleotide 
of upstream primer. The numbers in parentheses are the nucleotides numbered from the 
first A in the initiation site (ATP) of transcription of P-glycoprotein, which is taken as +1. 
Major transcription sites (underlined) and minor transcription sites (double underlined) 
are shown. Representative results were shown from triplicate experiments with 
essential similar results. 
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3.2.5 RHepG2 over-expressed Bcl-2 
Beside enhanced drug efflux, we further sought to investigate whether RHepG2 
cells have other resistance mechanisms other than P-glycoprotein over-expression. 
Bcl-2 is an important modulator of apoptosis. It stabilizes the mitochondrial 
transmembrane potential by regulating the proton efflux and inhibits generation of 
reactive oxygen species (Solary et al., 2002). So, we investigated whether Bcl-2 was 
over-expressed in RHepG2 cells, making RHepG2 cells resistant to doxorubicin and 
taxol. 
Proteins from HepG2 and RHepG2 cells were extracted and subjected to 
Western analysis. Anti-Bcl-2 antibody which binds specifically to Bcl-2 protein was 
employed and the amount of target proteins was determined with enhanced 
chemiluminence (ECL) assay as described in Materials and Methods. 
As shown in Figure 3.2.5.1，we found that Bcl-2 was over-expressed in RHepG2 
cells when compared with that of HepG2 cells. On the contrary, no significant 
difference was found in the house-keeping protein Grp75. This difference in Bcl-2 
might contribute to the resistance of RHepG2 cells to doxorubicin induced 
cytotoxicity and valinomycin-induced mitochondrial depolarization. 
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Figure 3.2.5.1 Expression of Bcl-2 protein in HepG2 and RHepG2 cells. 
‘P ro t e in s from untreated HepG2 and RHepG2 cells were extracted and analyzed in 
12% SDS-PAGE. After Western blotting, anti-Bcl-2 antibody was used to 
specifically probe Bcl-2 protein. Representative results were shown from 
triplicate experiments with essential similar results. 
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3.2.6 HepG2 and RHepG2 cells had the same level of Bax protein 
Since the Bcl-2 family proteins are key regulators of apoptosis, in addition to 
Bcl-2, we investigated another member of the Bcl-2 family, the Bax protein. Bax is 
a promoter of apoptosis by damaging the outer mitochondrial membrane, leading to 
the release of apoptotic mediators like cytochrome c and AIF (Cory et al., 2003). 
Proteins from HepG2 and RHepG2 cells were extracted and subjected to 
Western analysis. Anti-Bax antibody which binds specifically to Bax protein was 
employed and the amount of target proteins was estimated with enhanced 
chemiluminence (ECL) assay as described in Materials and Methods. 
It was found from Figure 3.2.6.1 that the expression level of Bax proteins was 
more or less the same in HepG2 and RHepG2 cells. Along with this, the expression 
of the house-keeping protein was also similar. Taken together, the pro-apoptotic 
protein Bax did not contribute to the resistance mechanism in RHepG2 cells. 
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HepG2 RHepG2 
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Figure 3.2.6.1 Expression of Bax protein in HepG2 and RHepG2 cells. 
“Proteins from untreated HepG2 and RHepG2 cells were extracted and analyzed in 
12% SDS-PAGE. After Western blotting, anti-Bax antibody was used to 
specifically probe Bax protein. Representative results were shown from 
‘ triplicate experiments with essential similar results. 
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Having confirmed the MDR in RHepG2 cells, we began to investigate the 
anti-cancer effects of Polyphyllin D in the parental HepG2, and the MDR in RHepG2 
cells. Also, the resistance reversal effects of Polyphyllin D in RHepG2 cells were 
also examined. The cytotoxic effect of Polyphyllin D was investigated first. 
4.1 Cytotoxicity of Polyphyllin D in HepG2 and RHepG2 cells 
4.1.1 Polyphyllin D exhibited cytotoxic effect in both HepG2 and RHepGl 
cells 
Many anti-cancer drugs cause cell death in cancer cells. We investigated 
whether Polyphyllin D is cytotoxic to HepG2 and RHepG2 cells. Since RHepG2 
cells exhibit MDR properties, this will also tell us whether the effect of Polyphyllin D 
, i s diminished in multidrug resistant cells. 
HepG2 and RHepG2 cells were treated with various doses of Polyphyllin D for 
24 hours. After treatment, cell viability was assessed by alamarBlue as mentioned in 
Materials and Methods. 
From Figure 4.1.1.1, it was found that Polyphyllin D caused cell death in both 
HepG2 and RHepG2 cells in a dose-dependent manner. Interestingly, the 
cytotoxicity of Polyphyllin D was more or less the same in HepG2 and RHepG2 cells, 
with an IC50 of about 5[iM. This suggests that RHepG2 cells did not show MDR to 
Polyphyllin D. 
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Cytotoxicity of Polyphyllin D in HepG2 cells 
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Figure 4.1.1.1 Effect of Polyphyllin D on cytotoxicity in HepG2 and 
RHepG2 cells after 24-hour treatment. HepG2 (1.5 x 10^/ml) and RHepG2 
(2.0 X lOVml) cells were seeded in 96-well plates overnight at 37�C, 5% CO2. 
Various concentrations of Polyphyllin D were added and the plates were then 
incubated for 24 hours at 37°C, 5% CO2. After incubation, cytotoxicity assay 
was carried out with alamarBlue as mentioned in Materials and Methods. 
Results are mean 士 SD for at least 6 determinations. Representative results were 
shown from duplicate experiments with essential similar results. 
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4.2 Apoptotic mechanism caused by Polyphyllin D in HepG2 and RHepG2 
cells 
4.2.1 Polyphyllin D caused apoptosis in HepG2 and RHepG2 cells 
Cell death occurs by two main types, necrosis or apoptosis. Apoptosis, or 
programmed cell death, is the major mechanism by which cancer cells are eliminated 
by anti-cancer drugs (Solary et al, 2002). 
To test if Polyphyllin D induces apoptosis rather than necrosis in HepG2 and 
RHepG2 cells, Annexin-V-FITC (Annexin-V) and propidium iodide (PI) were 
employed. Annexin-V is a human vascular anti-coagulant protein which has a high 
affinity for phosphatidylserine (PS). In normal viable cells, PS is located on the 
•cytoplasmic s urface o f t he c ell m embrane. In t h e e arly s tages o f a poptosis, PS is 
translocated from the inner side to the outer side of the plasma membrane. This 
allows macrophages to recognize and engulf cells undergoing apoptosis, thus 
protecting organisms from the exposure to cellular compounds leading to 
inflammation, which mainly accompanies necrosis (Bergmann and Steller, 2002). 
Since necrotic cells also expose PS with the loss of membrane integrity, to 
differentiate apoptotic from necrotic cells, cells were co-stained with the DNA stain 
PL In cells undergoing early apoptosis, the plasma membrane is intact and PI cannot 
enter the cell, so these cells can only be recognized by annexin-V, but cannot be 
stained by PL On the contrary, if cells are undergoing necrosis or at the late-phase of 
apoptosis, the plasma membrane integrity loses and cells can be stained by PL 
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As a positive control, Img/ml digitonin was added to untreated cells for 15 
minutes to permeabilize the plasma membrane. It allowed both Annexin-V and PI to 
enter cells to binds to PS and DNA respectively and gave signals for Annexin-V- and 
Pl-positive cell population (Figure 4.2.1.1). 









Figure 4.2.1.1 Schematic layout of cell distribution after 
Annexin-V and PI staining 
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Figure 4.2.1.2 Effect of Polyphyllin D on the induction of apoptosis in 
HepG2 cells. HepG2 (1.5 x 107ml) cells were seeded in 150cm^ culture flasks 
overnight at 37®C, 5% CO2. Various concentrations of Polyphyllin D was added 
and then incubated for 24 hours at 37®C, 5% CO2. After incubation, cells were 
collected and stained with Annexin-V and PI and then subjected to flow 
cytometric analysis at 530nm (FL-1 channel) and beyond 650nm (FL-3 channel) 
respectively. The figure at the comer represents the % of cell population fell in 
the corresponding quadrant. Ten thousand cells were analyzed in each treatment. 
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Figure 4.2.1.3 Effect of Polyphyllin D on the induction of apoptosis in 
RHepG2 cells. RHepG2 (2.0 x lOVml) cells were seeded in 150cm^ culture 
flasks overnight at 37�C 5%C02. Various concentrations of Polyphyllin D was 
added and then incubated for 24 hours at 37�C, 5% CO2. After incubation, cells 
were collected and stained with Annexin-V and PI and then subjected to flow 
cytometric analysis at 530nm (FL-1 channel) and beyond 650nm (FL-3 channel) 
respectively. The figure at the comer represents the % of cell population fell in 
the corresponding quadrant. Ten thousand cells were analyzed in each treatment. 
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From Figure 4.2.1.2 and 4.2.1.3，it was found that S i^M Polyphyllin D caused 
15.30/0 of HepG2 and 27.3% of RHepG2 cells to enter the early phase of apoptosis. 
Moreover, the percentage of cells in the early apoptosis stage was more than that of 
the late apoptosis/necrosis stage after Polyphyllin D treatments suggesting that 
induction of apoptosis is the major response triggered by Polyphyllin D. 
Interestingly, Polyphyllin D is more effective in inducing apoptosis in RHepG2 cells 
than that in HepG2 cells. From this assay, we can conclude that Polyphyllin D 
caused cell death in HepG2 and RHepG2 cells by apoptosis. 
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4.2.2 Polyphyllin D did not activate caspase 8 
There are two major signaling routes in mammalian cells leading to apoptosis, 
the extrinsic and the intrinsic pathway (Sun et al., 1999). A key mediator of the 
extrinsic apoptotic pathway is caspase 8, so we first tested if caspase 8 is activated 
after Polyphyllin D treatment. 
HepG2 and RHepG2 cells were treated with various doses of Polyphyllin D for 
24 hours. After that, cellular proteins were extracted and subjected to Western 
analysis. Anti-caspase 8 antibody which binds specifically to pro-caspase 8 and 
active forms of caspase 8 was employed and the amount of target proteins was 
estimated with enhanced chemiluminence (ECL) assay as described in Materials and 
Methods. 
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Figure 4.2.2.1 Effect of Polyphyllin D in caspase 8 activation in HepG2 and 
RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 (2.0 x lOVml) cells were 
seeded in 150cm^ culture flasks overnight at 37°C, 5% CO2. Various 
concentrations of Polyphyllin D were added and cells were then incubated for 24 
hours at 37°C, 5% CO2. After incubation, proteins were extracted and analyzed 
with Western blotting. After Western blotting, anti-caspase 8 antibody was used 
to specifically probe caspase 8 proteins. Solvent control was prepared by treating 
cells with 0.01% DMSO, which is equivalent to the DMSO content in 5[iM 
Polyphyllin D. 
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The anti-caspase 8 antibody we employed can bind to both the proenzyme 
(55/50kDa doublet) and the cleave products (40/36kDa doublet and 23kDa). From 
Figure 4.2.2.1, we did not see a trend of reduction in the caspase 8 proenzyme, nor the 
presence of the cleaved products of caspase 8. On the other hand, the protein level 
of Grp75 did not change in HepG2 and RHepG2 cells after treatments. These 
observations suggest that Polyphyllin D did not induce apoptosis via the extrinsic 
apoptotic pathway through the activation of caspase 8. 
t* 
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4.2.3 Polyphyllin D did not concentrate on the plasma membrane of cells 
For Polyphyllin' D to activate the extrinsic apoptotic pathway, it must interact 
with the extracellular death receptors. To visualize the distribution of Polyphyllin D 
in cells, a fluorescent-labeled Polyphyllin D derivative called HK-Pl (Figure 4.2.3.1) 
was produced by Professor B. Yu. HK-Pl consists of a Polyphyllin D molecule and 
a dansyl group attached to the polysaccharide moiety of Polyphyllin D. HK-Pl can 
be excited at 360nm and emits fluorescence at 530nm. 
^ N . Dansyl group 
• C协 i斤、 
P ^ o 八 ” 
HOCZ^ ？ HO HO OH 
Figure 4.2.3.1 Structure of HK-Pl, the fluorescent derivative of 
Polyphyllin D. 
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In this experiment, HepG2 cells were loaded with HK-Pl (lOO^iM) for 30 minutes. 
After that, cells were then visualized under fluorescence microscope. 
As shown in Figure 4.2.3.2，HepG2 cells loaded with HK-Pl showed green 
fluorescence throughout the cell, but not exclusively located around the plasma 
membrane. So, it is not likely that Polyphyllin D induces apoptosis through the 
extrinsic death receptor pathway. Moreover, since there was green fluorescence 
throughout the cells, it is possible that Polyphyllin D could diffuse into the cytosol 
and elicited apoptosis through the intrinsic pathway. • 
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Figure 4.2.3.2 Distribution of HK-Pl in HepG2 cells. HepG2 (1.5 x lOVml) 
cells were seeded in glass coverslips overnight at 37®C, 5% CO2. HK-Pl 
(100|LIM) was added and then incubated for 30 minutes at ST^ 'C, 5% CO2 in dark. 
After incubation, cells were observed under light and fluorescence microscope. 
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4.2.4 Polyphyllin D did not change Bcl-2 levels in HepG2 & RHepG2 cells 
The proteins in the Bcl-2 family are important regulators of apoptosis in cells. 
We wonder whether Polyphyllin D treatment caused apoptosis in cells by changing 
the expression level of proteins in this family. We first investigated the level of 
Bcl-2, the anti-apoptotic member of the Bcl-2 family proteins. 
HepG2 and RHepG2 cells were treated with Polyphyllin D for 24 hours. After 
that, proteins were extracted from cells and analyzed with Western analysis and 
probed with anti-Bcl-2 antibody. 
From Figure 4.2.4.1，we can see that the Bcl-2 levels in HepG2 & RHepG2 cells 
were unchanged after Polyphyllin D treatment. 
� . 
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Figure 4.2.4.1 Effect of Polyphyllin D on Bcl-2 expression level in HepG2 
and RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 (2 x 10^/ml) cells were 
seeded in culture flasks overnight at 37�C，5% CO2. Various concentrations of 
Polyphyllin D was added and then incubated for 24 hours at 37�C，5% CO2. � After incubation, cells were collected and proteins were extracted with Img/ml 
digitonin lysis buffer as mentioned in Materials and Methods. The extracted 
proteins were then subjected to Western analysis and probed with anti-Bcl-2 
antibody. Solvent control was prepared by treating cells with 0.01% DMSO, 
which is equivalent to the DMSO content in 5\xM Polyphyllin D. Representative 
results were shown from triplicate experiments with essential similar results. 
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4.2.5 Polyphyllin D treatment enhanced Bax protein expression in both 
HepG2 and RHepG2 cells 
Beside the anti-apoptotic Bcl-2, the expression level of another Bcl-2 family 
protein after treatment, Bax, was also investigated. 
Again, HepG2 and RHepG2 cells were treated with Polyphyllin D for 24 hours. 
Cellular proteins were then extracted from cells and analyzed with Western analysis 
and probed with anti-Bax antibody. 
As can be seen in Figure 4.2.5.1, the Bax level in HepG2 and RHepG2 cells was 
up-regulated after Polyphyllin D treatment. 
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Figure 4.2.5.1 Effect of Polyphyllin D on Bax expression level in HepG2 and 
RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 (2 x lOVml) cells were 
seeded in culture flasks overnight at 37�C, 5% CO2. Polyphyllin D ( 2 . 5 _ was 
added and then incubated for 24 hours at 3TC, 5% CO2. After incubation, cells 
were collected and proteins were extracted with Img/ml digitonin lysis buffer as 
mentioned in Materials and Methods. The extracted proteins were then subjected 
to Western analysis and probed with anti-Bcl-2 antibody. Solvent control was 
prepared by treating cells with 0.01% DMSO, which is equivalent to the DMSO 
content in 5|LIM Polyphyllin D. Representative results were shown from 
triplicate experiments with essential similar results. 
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4.2.6 Polyphyllin D caused cytochrome c and AIF release in HepG2 and 
RHepG2 cells 
In intrinsic mitochondrial pathway, permeabilization of the outer mitochondrial 
membrane and the subsequent release of apoptotic mediators that are previously 
present in the intermembraneous space occur. 
Among the molecules released from the intermembraneous space of 
mitochondria, cytochrome c, a 14.5kDa protein is one of the important regulators that 
controls the life and death of cells (Kroemer and Reed, 2000). Upon entry into the 
cytosol, cytochrome c induces oligomerization of Apaf-1, allowing it to bind to 
cytosolic pro-caspase 9 and leads to its activation. So, cytochrome c is an important 
mediator that transmits apoptotic signal from mitochondria to the other parts of the 
cells to elicit apoptosis (Ravagnan et al., 2002). 
Again, HepG2 and RHepG2 cells were treated with various doses of Polyphyllin 
D for 18 and 24 hours. Cells were then collected and their cytosolic proteins were 
extracted with the use of lysis buffer with a carefully adjusted dose of digitonin so 
that only the plasma membrane is permeabilized and the mitochondrial membranes 
remain intact. The collected protein was then subjected to Western analysis and 
probed with anti-cytochrome c antibody as mentioned in Materials and Methods. 
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Figure 4.2.6.1 Effect of Polyphyllin D on cytochrome c release in HepG2 
and RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 (2 x lOVml) cells were 
seeded in culture flasks overnight at 37°C, 5% CO2. Various concentrations of 
Polyphyllin D was added and then incubated for 24 hours at 37�C, 5% CO2. 
After incubation, cells were collected and proteins were extracted with Img/ml 
digitonin lysis buffer as mentioned in Materials and Methods. The extracted 
proteins were then subjected to Western analysis and probed with anti-cytochrome 
c antibody. Solvent control was prepared by treating cells with 0.01% DMSO, 
which is equivalent to the DMSO content in 5[iM Polyphyllin D. Representative 
results were shown from triplicate experiments with essential similar results. 
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In addition to cytochrome c, mitochondria release other proteins from the 
intermembraneous space to induce morphological changes independent of the 
activation of caspases. 
AIF is a 57kDa flavoprotein originally presents in the intermembraneous space 
of mitochondria (Kroemer and Reed, 2000). Upon apoptosis induction, AIF 
translocates from the mitochondria to the nucleus and triggers c aspase-independent 
nuclear changes. 
HepG2 and RHepG2 cells were treated with Polyphyllin D for 18 and 24 hours. 
Cytosolic proteins were e xtracted with the digitonin lysis buffer again as described 
before. The extracted proteins were then analyzed with Western analysis and probed 
with anti-AIF antibody. 
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Figure 4.2.6.2 Effect of Polyphyllin D on AIF release in HepG2 and 
RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 (2 x lOVml) cells were 
seeded in culture flasks overnight at 37�C，5% CO2. Various concentrations of 
Polyphyllin D was added and then incubated for 24 hours at 37°C, 5% CO2. 
After incubation, cells were collected and proteins were extracted with Img/ml 
digitonin lysis buffer as mentioned in Materials and Methods. The extracted 
proteins were then subjected to Western analysis and probed with anti-AIF 
antibody. Solvent control was prepared by treating cells with 0.01% DMSO, 
which is equivalent to the DMSO content in 5|j,M Polyphyllin D. Representative 
results were shown from triplicate experiments with essential similar results. 
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As shown in Figure 4.2.6.1 and 4.2.6.2, Polyphyllin D caused the release of 
cytochrome c and AIF in both HepG2 and RHepG2 cells in a dose-dependent manner 
after 18 or 24 hours treatments. This indicated that Polyphyllin D induced 
permeabilization of the outer mitochondrial membrane that releases apoptotic signals 
from mitochondria to the other parts of the cells for the caspases-dependent and 
independent death execution. . 
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4.2.7 Polyphyllin D induced mitochondrial membrane depolarization in 
HepG2 and RHepG2 cells 
Most apoptosis mediated through the intrinsic pathway involves the 
permeabilization of the inner mitochondrial membrane and manifested by the 
depolarization of mitochondria transmembrane potential. Permeabilization of the 
inner mitochondrial membrane dissipates the proton gradient that results from the 
respiration-driven, electron transport chain mediated pumping of these protons 
responsible for the mitochondrial membrane potential. With this concept in our 
mind, we tested the functioning of the mitochondria with the mitochondria specific, 
potential-dependent dye JC-1. 
HepG2 and RHepG2 cells were treated with various doses of Polyphyllin D for 
t* 
24 hours. Cells were then collected and stained with JC-1, and then subjected to 
flow cytometry analysis as described in Materials and Methods. 
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Figure 4.2.7.1 Effect of Polyphyllin D on mitochondrial membrane 
depolarization in HepG2 cells. HepG2 cells (1.5 x loVml) were seeded in 
100mm culture dishes overnight at 37�C，5%C02. Various concentrations of 
Polyphyllin D was added and then incubated for 24 hours at 37�C，5% CO2. 
After incubation, cells were collected and stained with JC-1 and then subjected to 
flow cytometric analysis at 530nm (FL-1 channel) and beyond 650nm (FL-3 
channel). 
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Figure 4.2.7.2 Effect of Polyphyllin D on mitochondrial membrane 
depolarization in RHepG2 cells. RHepG2 cells (2 x lOVml) were seeded in 
100mm culture dishes overnight at 37°C, 5% CO2. Different concentrations of 
Polyphyllin D was added and then incubated for 24 hours at 37®C, 5% CO2. 
After incubation, cells were collected and stained with JC-1 and then subjected to 
flow cytometric analysis at 530nm (FL-1 channel) and beyond 650nm (FL-3 
channel). 
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As shown in Figures 4.2.7.1 and 4.2.7.2，Polyphyllin D caused the 
mitochondria in both HepG2 and RHepG2 cells to depolarize in a dose-dependent 
manner. It was found that 2.5|J.M Polyphyllin D caused 25.81% of HepG2 and 
33.16% of RHepG2 cells to depolarize mitochondrial potential whereas 5|j,M of 
Polyphyllin D caused 4 8.51% o f H e p G 2 and 5 3.48% o fRHepG2 cells to have 
depolarized mitochondrial potential. For cells treated with lOjiM of Polyphyllin 
D, 74.9% of HepG2 and 70.75% of RHepG2 cells were found to have depolarized 
mitochondrial potential. Also, it seems likely that RHepG2 cells were more 
sensitive to Polyphyllin D in terms of mitochondrial depolarization. From this 
assay, we can conclude that Polyphyllin D caused apoptosis in HepG2 and 
RHepG2 cells largely via the intrinsic mitochondrial pathway. 
t* 
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4.2.8 Polyphyllin D caused mitochondrial swelling in HepG2 and clustering 
of mitochondria in RHepG2 cells 
Morphological changes of mitochondria usually accompany apoptosis elicited 
with the intrinsic pathway. We examined the changes in the mitochondria of HepG2 
and RHepG2 after Polyphyllin D treatment with the mitochondria-specific dye JC-1 
by confocal laser scanning microscopy. 
In this study, HepG2 and RHepG2 cells were treated with or without Polyphyllin 
D (2.5i^M) for 21 hours and stained with JC-1 during the last 3 hours. At the end of 
experiment, cells were then stained with a high dose of acridine orange (AO) for the 
location of cell nucleus. 
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Figure 4.2.8.1 Effect of Polyphyllin D on the size of mitochondrial in HepG2 
cells. HepG2 cells (5 x 10 )^ were seeded in glass coverslips overnight at 37°C, 
5% CO2. Polyphyllin D ( 2 . 5 _ was added and then incubated overnight at 
37°C, 50/0 CO2, After incubation, cells were collected and stained with JC-1 and 
then subjected to confocal analysis, (a) Untreated HepG2 cells incubated with 
complete medium were stained with JC-1 (green). The yellow arrows indicated 
the elongated mitochondria in untreated HepG2 cells, (b) HepG2 cells incubated 
with 2.5|^M Polyphyllin D were stained with JC-1 (yellow) and AO (red). The 
green and blue arrows indicated the swollen and clustered mitochondria after 
Polyphyllin D treatment, (c) HepG2 cells incubated with medium without FBS, 
JC-1 (blue) and AO (red). Panel (c) is an enlarged illustration of. the apoptotic 
cell. The cool and the warm color indicated the lower and the higher 
fluorescence intensity, respectively. 
一 
V 
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Figure 4.2.8.2 Effect of Polyphyllin D on mitochondrial aggregation in 
RHepG2 cells. RHepG2 cells (5 x lO') 
were seeded in glass coverslips 
overnight at 37®C, 5%C02. Polyphyllin D (2.5^M) was added and then 
incubated overnight at 37®C, 5% CO2. After incubation, cells were collected and 
stained with JC-1, and then subjected to confocal microscopy analysis. 
Untreated RHepG2 cells incubated with complete medium were showed in (a) 
fluorescence signal and (b) an overlay photo of fluorescence and white light image. 
RHepG2 cells treated with 2.5fiM Polyphyllin D were showed in (c) fluorescence 
signal and (d) an overlay photo of fluorescence and white light image. The pink 
arrows indicated the aggregated mitochondria after Polyphyllin D treatment. 
The cool and the warm color indicated the lower and the higher fluorescence 
intensity, respectively. 
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From Figure 4.2.8.1, we can see that the morphology of the mitochondria of 
HepG2 cells changed from the elongated shape (Figure 4.2.8.1a (yellow arrows)) to 
oval shape (Figure 4.2.8.1b (green arrows)) after Polyphyllin D treatment, suggesting 
that Polyphyllin D elicited mitochondrial swelling in HepG2 cells. Similarly, 
mitochondrial swelling in HepG2 cells was also observed after serum deprivation 
(Figure 4.2.8.1c) which acts as a p ositive control for the assay. Besides swelling, 
clustering of mitochondria was also observed in Polyphyllin D treated HepG2 cells 
(Figure 4.2.8.1b, (blue arrows)) but not in serum-deprived cells (Figure 4.2.8.1c). 
For RHepG2 cells, it is obvious that mitochondria formed aggregates after 
Polyphyllin D treatment (Figure 4.2.8.2c, (pink arrows)) when compared with 
untreated cells (Figure 4.2.8.2a). Since mitochondria swelling and clustering has 
been found in cells undergoing apoptosis (Haga et al, 2003)，these results further 
t* 
confirmed the participation of mitochondria in Polyphyllin D-induced apoptosis. 
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4.2.9 Polyphyllin D caused H2O2 release in HepG2 and RHepG2 cells, and 
the cytotoxic effects of Polyphyllin D could be reduced by NAC 
Reactive oxygen species (ROS) has been known as an apoptosis-promoting 
factor for a long time. The production of ROS occurs in the mitochondria along 
with the respiratory chain. When the mitochondrial membrane becomes leaky, 
more ROS will be generated and damage various organelles and proteins (Higuchi, 
2003). 
Again, HepG2 and RHepG2 cells were treated with various doses of 
Polyphyllin D and stained with the fluorescent dye carboxy-HzDCFDA. 
Carboxy-H2DCFDA can passively diffuse into cells and, when cleaved by 
esterases in cells, it becomes negatively charged carboxy-HzDCF and impedes its 
9* 
leakage out of the cell. Once inside the cytosol, carboxy-HiDCF is oxidized by 
hydrogen peroxide and becomes carboxy-DCF that emits green fluorescence 
(www.probes • com). 
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Figure 4.2.9.1 Effect of Polyphyllin D on the production of ROS in HepG2 
and RHepG2 cells. HepG2 (1.5 x lOVml) and RHepG2 cells (2 x lOVml) were 
seeded in 100mm culture dishes overnight at 37�C, 5% CO2. Various 
concentrations of Polyphyllin D was added and then incubated for 24 hours at 
3TC, 5% CO2. After incubation, cells were collected and stained with 
carboxy-H2DCFDA and then subjected to flow cytometric analysis at 530nm 
(FL-1 channel). 
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From the results of flow cytometric analysis (Figure 4.2.9.1)，we found that 
both HepG2 and RHepG2 cells released H2O2 in a dose-dependent manner upon 
Polyphyllin D treatments. After treatment with 2.5 and 5|aM of Polyphyllin D, 
the percentage of cells in the Ml region increased from the basal level of 42.75% 
to 49.99 and 58.23% respectively in HepG2 cells, and increased from 33.46% to 
52.85% and 69.99% in RHepG2 cells. The findings also suggest that RHepG2 
cells were more sensitive to Polyphyllin D for ROS formation. 
To evaluate the effects of H2O2 in cell viability, we pretreated HepG2 and 
RHepG2 cells with N-acetyl L-cysteine (NAC). NAC is a thiol antioxidant that 
is a precursor of the cellular anti-oxidant GSH, which in turn catalyzes the 
reaction that turns H2O2 into oxygen and water molecules. 
HepG2 and RHepG2 cells were pretreated with 25mM NAC for 2 hours. 
Then Polyphyllin D of various concentrations was added to the medium and cells 
were incubated for 24 hours further. Subsequently, cell viability was assessed by 
alamarBlue assay. 
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Figure 4.2.9.2 Effect of Polyphyllin D on cytotoxicity in HepG2 and 
RHepG2 cells with or without NAC pretreatment. HepG2 (1.5 x loVml) and 
RHepG2 (2.0 x lOVml) cells were seeded in 96-well plates overnight at 37®C, 5% 
CO2. Cells were pretreated with 25mM NAC for 2 hours. Various 
concentrations of Polyphyllin D were added and cells were then incubated for 24 
hours at 37°C, 5% CO2. After incubation, cytotoxicity assay was carried out 
with alamarBlue as mentioned in Materials and Methods. Results are mean 士 SD 
for at least 6 determinations. Results marked with * had significantly (P<0.001) 
higher viability than cells without NAC pretreatment. Statistical analysis was 
performed by the Student's t-Test. 
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From Figure 4.2.9.2, it can be seen that incubating cells with NAC reduced 
Polyphyllin D-induced cytotoxicity in both HepG2 and RHepG2 cells. Taken 
together, we found that Polyphyllin D caused the release of H2O2 in HepG2 and 
RHepG2 cells, and the removal of H2O2 prevented Polyphyllin D-induced cell 
death. 
f 
Chapter 4 Results - Effects of Polyphyllin D in HepG2 and RHepG2 cells Page 132 
4.2.10 Polyphyllin D caused permeabilization of lysosomes 
Lysosomes have been considered to be organelles that are involved in necrotic 
and apoptotic cell death which are responsible for the cellular degradation processes. 
(Brunk et al., 2001). We therefore tested whether Polyphyllin D action involves 
lysosomal rupture, by examining Polyphyllin D treated or untreated cells with the 
lysosomotropic dye acridine orange (AO). When living cells are exposed to a low 
concentration of AO, AO molecules accumulate in lysosomes by active 
transportations and give rise red granular fluorescence. Upon lysosomal rupture, AO 
leaks out from lysosomes, and give nuclear and diffuse cytosolic fluorescence that is 
partially shifted to green after binding to nucleic acids (Brunk et al., 1997). 
In our study, HepG2 and RHepG2 cells were treated with Polyphyllin D (2.5|iM) 
0* 
for 21 hours and loaded with a low dose of AO during the last 3 hours. Cells were 
then analyzed under confocal microscopy. From Figures 4.2.10.1 and 4.2.10.2，we 
can see that both HepG2 and RHepG2 cells showed nuclear and diffuse cytosolic 
fluorescence after Polyphyllin D treatment. This indicates that lysosomal rupture 
was involved in Polyphylliii D induced apoptosis in HepG2 and RHepG2 cells. 
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Figure 4.2.10.1 Effect of Polyphyllin D on the permeabilization of lysosomes 
in HepG2 cells. HepG2 cells (5 x 10 )^ were seeded on coverslips overnight at 
37°C, 5%C02. Cells with or without Polyphyllin D (2.5|iM) treatment was 
incubated overnight at 37°C, 5% CO2. After incubation, cells were collected and 
stained with AO (16nM), and then subjected to confocal analysis. Untreated 
HepG2 cells incubated with complete medium were showed in (a) fluorescence 
signal and (b) an overlay photo of AO fluorescence and white light image. 
HepG2 cells treated with 2.5}iM Polyphyllin D were showed (c) fluorescence 
signal and (d) an overlay photo of AO fluorescence and white light image. The 
cool and the warm color indicated the lower and the higher fluorescence intensity, 
respectively. 
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Figure 4.2.10.2 Effect of Polyphyllin D on the permeabilization of lysosomes 
in RHepG2 cells. RHepG2 cells (5 x 10 )^ were seeded in glass cover slips 
overnight at 37°C, 5%C02. Cells with or without Polyphyllin D (2.5^M) 
treatment was incubated overnight at 37®C, 5% CO2. After incubation, cells 
were collected and stained with AO, and then subjected to confocal analysis. 
Untreated RHepG2 cells incubated with complete medium were showed in (a) 
fluorescence signal and (b) an overlay photo of AO fluorescence and white light 
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4.3 Site of action of Polyphyllin D in cells 
Up to now," we found that Polyphyllin D caused apoptosis in HepG2 and 
RHepG2 cells via the intrinsic mitochondrial pathway. This may be brought about 
by its action on mitochondria directly, or by acting on other cellular proteins or 
organelles and then transmits the signal to mitochondria. 
To elucidate this, we tried to isolate the mitochondria from HepG2 and RHepG2 
cells, and then treated the isolated mitochondria with Polyphyllin D. 
4.3.1 Purity of isolated mitochondria 
Mitochondrial fraction of cells was isolated as mentioned in Materials and 
Methods. The purity of isolated mitochondria from HepG2 cells was analyzed with 
Western blotting and HepG2 whole cell lysate was prepared for comparison. 
As shown in Figure 4.3.1.1，whereas Grp75, the mitochondrial marker protein, 
was abundant in the isolated mitochondrial fraction, neither the nucleus marker 
protein Lamin B nor the cytosol marker protein (3-tubulin was found in the 
mitochondrial fraction. As a result, the isolated mitochondria were in high purity 
without nucleus or cytosol contamination. 
Chapter 4 Results - Effects of Polyphyllin D in HepG2 and RHepG2 cells 
Page 136 
Mitochondrial protein HepG2 
from two separate whole cell 
preparations 丨 ysate 
I 1 
. Grp75《75kDa) 
‘ Mitochondria marker protein 
Lamin B (70kDa) 
Nucleus marker protein 
.,麵,丨【‘丨、_丨… 舊 p-Tubulin (SOkDa) 
Cytosol marker protein 
Figure 4.3.1.1 Purity of isolated mitochondria. HepG2 cells were collected 
from culture flasks. Mitochondria were isolated with mitochondrial isolation kit 
as described in Materials and Methods. The isolated mitochondria, or HepG2 
whole cell, were then lysed with SDS lysis buffer. The same amount of protein 
was analyzed with Western blotting and probed with antibodies targeting different 
cell marker proteins. Representative results were shown from duplicate 
experiments with essential similar results. 
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4.3.2 Polyphyllin D caused cytochrome c release from the HepG2 and 
RHepG2 isolated mitochondria 
One important apoptosis mediator is cytochrome c, which is released from the 
intermembraneous s pace a fter o uter m itochondrial m embrane p ermeabilization. In 
section 4.2.5，we found that Polyphyllin D caused cytochrome c release from 
mitochondria in HepG2 and RHepG2 whole cells. Now, we examined whether 
Polyphyllin D has the same effect in isolated mitochondria. 
Mitochondria were isolated from HepG2 and RHepG2 cells. The isolated 
mitochondria were treated immediately with various doses of Polyphyllin D for 3 
hours. After that, the mitochondria pellet was pelleted and the resulting supernatant 
was concentrated and subjected to Western analysis. 
t* 
Solvent control was prepared by treating HepG2 cells with 0.04% DMSO, which 
is equivalent to the DMSO content in 20fiM Polyphyllin D. The release of 
cytochrome c from mitochondria treated with 0.04% DMSO was significantly less 
than those treated with 20 | l iM Polyphyllin D. 
‘ As shown in Figure 4.3.2.1, Polyphyllin D treatment caused a dose-dependent 
cytochrome c release from isolated mitochondria of HepG2 and RHepG2 cells. 
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Figure 4.3.2.1 Effect of Polyphyllin D on cytochrome c release in isolated 
HepG2 and RHepG2 mitochondria. Mitochondria from HepG2 and RHepG2 
cells were isolated and treated with various concentrations of Polyphyllin D for 3 
hours at 37°C. Proteins released into medium was concentrated and analyzed 
with Western blotting and probed with anti-cytochrome c antibody. 
Representative "results were shown from duplicate experiments with essential 
- similar results. 
� 
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4.3.3 Polyphyllin D induced mitochondrial depolarization in HepG2 and 
RHepG2 isolated mitochondria 
We also tested whether Polyphyllin D caused mitochondrial inner membrane 
permeabilization in isolated HepG2 and RHepG2 mitochondria by measuring the 
change in mitochondrial transmembrane potential after treatment. Mitochondria 
from HepG2 and RHepG2 were isolated and treated with various doses of Polyphyllin 
D for 30 minutes. The mitochondria were then stained with the 
mitochondria-specific fluorescent dye JC-1 and then subjected to flow cytometric 
analysis. 
As can be seen in Figure 4.3.3.1 and 4.3.3.2, Polyphyllin D caused a 
dose-dependent mitochondrial depolarization in both HepG2 and RHepG2 isolated 
mitochondria. In HepG2 group, depolarized mitochondria increased from 36.61% in 
control to 62.44% after 20|iM Polyphyllin D treatment. For RHepG2 group, 
depolarized mitochondria increased from 2 5.52% in control to 5 5.19% after 20|iM 
Polyphyllin D treatment. Similar to whole cell assay, RHepG2 cells seemed to be 
more sensitive to Polyphyllin D induced mitochondrial depolarization. From this 
assay, it was concluded that Polyphyllin D acted on mitochondria of HepG2 and 
RHepG2 cells directly to elicit apoptosis in cells. 
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Figure 4.3.3.1 Effect of Polyphyllin D on mitochondrial membrane 
depolarization in isolated HepGl mitochondria. Mitochondria from HepG2 
cells were isolated and stained with JC-1 at 37°C for 10 minutes. Mitochondria 
were then treated with various concentrations of Polyphyllin D for 3 hours at 37�C 
and subjected to flow cytometric analysis at 53Onm (FL-1 channel) and beyond 
650 nm (FL-3 channel). Solvent control was prepared by treating cells with 
0.04% DMSO, which is equivalent to the DMSO content in 20|iM Polyphyllin D. 
Representative results were shown from triplicate experiments with essential 
similar results. 
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Figure 4.3.3.2 Effect of Polyphyllin D on mitochondrial membrane 
depolarization in isolated RHepG2 mitochondria. Mitochondria from 
RHepG2 cells were isolated and stained with JC-1 at 37°C for 10 minutes. 
Mitochondria were then treated with various concentrations of Polyphyllin D for 3 
hours at 37®C and subjected to flow cytometric analysis at 530nm (FL-1 channel) 
and beyond 650nm (FL-3 channel). Solvent control was prepared by treating 
cells with 0.04% DMSO, which is equivalent to the DMSO content in 20^iM 
Polyphyllin D. Representative results were shown from triplicate experiments 
with essential similar results. 
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4.3.4 Polyphyllin D caused mitochondrial swelling in HepG2 and RHepG2 
isolated mitochondria 
Beside mitochondrial depolarization, mitochondrial swelling after Polyphyllin D 
treatment was also investigated. Mitochondria from HepG2 and RHepG2 were 
isolated and treated with 5 i^M Polyphyllin D for 30 minutes. The mitochondria were 
then analyzed with flow cytometry. The higher the FSC value, the larger is the size 
of the mitochondria. 
From Figure 4.3.4.1，isolated mitochondria from both HepG2 and RHepG2 cells 
were swollen after Polyphyllin D treatment. For HepG2 group, there was 26.17% 
mitochondria became swollen whereas in RHepG2 group, there was 35.36% 
mitochondria became swollen. Therefore, Polyphyllin D acted on the isolated 
mitochondria and caused them to swell. 
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Figure 4.3.4.1 Effect of Polyphyllin D on mitochondrial swelling in isolated 
HepG2 and RHepG2 mitochondria. Mitochondria from HepG2 and RHepG2 
cells were isolated and treated with 5\iM Polyphyllin D for 3 hours at 3TC and 
subjected to flow cytometric analysis. Representative results were shown from 
duplicate experiments with essential similar results. 
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4.4 Resistance reversal effects of Polyphyllin D in RHepG2 cells 
4.4.1 Polyphyllin D increased doxorubicin accumulation in RHepG2 cells 
One major resistance mechanism in RHepG2 cells is the enhanced expression of 
P-glycoprotein. Therefore, we sought to investigate whether Polyphyllin D can 
reverse the effect of P-glycoprotein expression to increase doxorubicin accumulation. 
RHepG2 c ells w ere grown i n m edium w ith 1.2|iM P olyphyllin D f or 6 d ays. 
Cells were incubated with 4|^ M doxorubicin for 3 hours before flow cytometric 
analysis. The amount of doxorubicin present in cells was proportional to 
fluorescence intensity measured in FL-3 channel. 
As shown in Figure 4.4.1.1, RHepG2 cells grown in medium with 1.2|iM 
Polyphyllin D enhanced doxorubicin accumulation in 40.39% of RHepG2 cells when 
compared with the control cells. Polyphyllin D at 1.2|aM was not a lethal dose for 
HepG2 and RHepG2 cells. As can be seen in Figure 4.1.1.1, more than 90% of cells 
were viable when treated with 1.2|aM Polyphyllin D for 24 hours. This suggests that 
Polyphyllin D may reverse the resistance in RHepG2 cells when judged by the 
doxorubicin accumulation. 
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Figure 4.4.1.1 Doxorubicin accumulation in RHepG2 cells with or without 
Polyphyllin D treatment. RHepG2 were grown in medium with or without 
\.2\iM Polyphyllin D for 6 days at 37�C’ 5% CO2. At the 6也 day, cells were 
incubated with 4|iM doxorubicin for 3 hours at 37°C, 5% CO2. After that, cells 
were collected and subjected to flow cytometric analysis beyond 650nm (FL-3 
channel). 
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4.4.2 P-glycoprotein expression was not down-regulated after Polyphyllin D 
treatment 
One possible reason for the enhanced doxorubicin accumulation in RHepG2 
cells after 6-day treatment with Polyphyllin D is the down-regulation of 
P-glycoprotein. Therefore, the level of P-glycoprotein expression in RHepG2 cells 
grown in Polyphyllin D was also examined. 
After treatment, RHepG2 cells were incubated with anti-P-glycoprotein 
antibody and subjected to flow cytometric analysis. As shown in Figure 4.4.2.1, the 
P-glycoprotein expression level was nearly the same (41.4% VS 43.4%) between the 
treated and control groups. Therefore, the increase in doxorubicin accumulation was 
not due to a decrease in P-glycoprotein expression in RHepG2 cells. 
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Figure 4.4.2.1 P-glycoprotein expression in RHepG2 cells with or without 
Polyphyllin D treatment. RHepG2 cells were grown in medium with or 
without 1.2|aM Polyphyllin D for 6 days at 37°C，5% CO2. Cells were collected 
and incubated with anti-P-glycoprotein antibody and then mouse-FITC antibody. 
After washing, cells were subjected to flow cytometric analysis at 530nm (FL-1 
channel). 
Chapter 4 Results 一 Effects of Polyphyllin D in HepG2 and RHepGl cells 
Page 148 
4.4.3 Co-treatment of doxorubicin with Polyphyllin D had enhanced cytotoxic 
effect 
In view of the increase in the doxorubicin accumulation by Polyphyllin D in 
RHepG2 cells, w e further investigated whether co-treatment ofRHepG2 cells with 
doxorubicin and Polyphyllin D enhanced cytotoxicity. 
RHepG2 cells were treated with doxorubicin, Polyphyllin D alone, or both for 
24 hours. After that, cell viability was estimated by alamarBlue as mentioned in 
materials and methods. 
As shown in Figure 4.4.3.1, co-treatment showed a higher cytotoxicity than that 
treated with doxorubicin or Polyphyllin D alone. This suggests that doxorubicin and 
Polyphyllin D acted on different targets and co-treatment of RHepG2 cells with 
doxorubicin and Polyphyllin D increased cell cytotoxicity. 
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Effects of Doxorubicin on RHepG2 Cells with or without Polyphyllin D co-treatment 
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Figure 4.4.3.1 Effect of Doxorubicin on cytotoxicity in HepG2 and RHepG2 
cells with or without Polyphyllin D co-treatment. RHepG2 (2.0 x 107ml) 
. c e l l s were seeded in 96-well plates overnight at 3TC, 5% CO2. Various 
concentrations of Polyphyllin D with or without doxorubicin were added and the 
plates were then incubated for 24 hours at 37°C, 5% CO2. After incubation, 
cytotoxicity assay was carried out with alamarBlue as mentioned in Materials and 
Methods. Results are mean 土 SD for at least 6 determinations. Bars marked 
with * are significantly different from bar 4 (treated with 4|iM doxorubicin and 
2.5|iM Polyphyllin D) (P<0.001). Bars marked with # are significantly 
different from bar 4 (treated with 4|iM doxorubicin and 2.5jiM Polyphyllin D) 
(P<0.001). Statistical analysis was performed by the Student's t-Test. 




in RHepG2 cells 
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5.1 Resistance of RHepG2 cells towards various chemical agents 
Resistance to chemotherapeutic drugs is a principal problem in the treatment of 
cancer (Tomida and Tsumo, 2002; Blagosklonny, 2003; Bichat et al, 1998). 
Extensive laboratory studies on the mechanisms of drug resistance show that MDR is 
a complex phenomenon, reflected by a vast array of genetic, molecular and 
biochemical alterations in the resistant cells (van Brussel et al.’ 2004). To study the 
properties of multi-drug resistant cells, a cell line called RHepG2 was developed by 
growing HepG2 cells with doxorubicin in a stepwise increasing dose manner (Chan et 
al., 2000). 
Doxorubicin is a broad spectrum anthracycline antibiotic used to treat a variety 
of cancers (Kotamraju et al., 2000). Its cytotoxic effect in cells is generated through 
three major ways. First, doxorubicin may stabilize the otherwise cleavable complex 
between DNA and homodimeric topoisomerase II enzyme subunits, resulting in the 
formation of protein-linked DNA double strand breaks (De Beer et al., 2001). 
Second, doxorubicin intercalates into chromosomal DNA and inhibits DNA 
polymerase for nucleic acid, synthesis (De Beer et al, 2001). Third, doxorubicin 
generates reactive oxygen spedes which damage proteins, 1 ipids and D N A o f cells 
and leads to cell death (Harbottle et al., 2001). 
With the evidence from our results that doxorubicin had a much lower cytotoxic 
effect in RHepG2 cells when compared with that of the parental HepG2 cells (Figure 
3.1.1.1), we then investigated whether RHepG2 cells are resistant to another 
anti-cancer drug taxol (Paclitaxel). 
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Taxol is a natural diterpenoid anti-cancer agent. It exerts its therapeutic effect, 
at least in part, by their ability to bind to the (3-subunit of tubulin, resulting in the 
formation of stable, non-functional microtubule bundles and thus interfering mitosis 
in the G2/M-phase junction (Crown and O'Leary, 2000; Jordan et al.’ 1993). The 
action of taxol is different from other anti-cancer drugs, such as the DNA-damaging 
agents, and distinct mechanisms underlying the induction of apoptosis and drug 
resistance have been suggested (O'Connor et al., 1997). Our results (Figure 3.1.2.1) 
showed that RHepG2 cells were also resistant to taxol despite the different action 
mechanism of taxol. 
In another investigation, we studied whether RHepG2 cells have different 
response towards valinomycin in comparison to that of HepG2 cells. Valinomycin is 
a potassium ionophore that is well known to cause the collapse of the mitochondrial 
membrane potential. It causes apoptosis in hepatoma cells that is independent of the 
anti-apoptotic members o f the Bcl-2 family (Inai et al., 1997). Results from flow 
cytometry showed that RHepG2 cells are resistant to valinomycin in terms of induced 
mitochondrial membrane depolarization (Figure 3.1.3.1), the mechanism that 
valinomycin causes apoptosis in other cell types. These results indicate that the 
resistance of RHepG2 cells towards valinomycin is, at least in part, contributed by an 
unknown mechanism upstream of mitochondria. 
Our results therefore indicated that RHepG2 cells were not only resistant to 
doxorubicin, the primary drug used to induce the resistance, but also other chemical 
agents that is structurally and functionally unrelated. These results are in line with 
the reported observations that RHepG2 cells are resistant to other anti-cancer drugs, 
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vincristine and methotrexate induced cytotoxicity (Chan et al., 2000). Similar 
observations in multi-drug resistant cell lines has been reported by Guo and 
co-workers (1997.) that by incubating human bladder cancer cell line, BIU-87 cells 
with stepwise increasing dose of doxorubicin, cross-resistance to doxorubicin 
derivatives (epirubicin, daunorubicin), vincristine, and etoposide was observed. This 
MDR phenomenon is commonly found in many cancer cells after drug treatment for a 
period of time (Gerlach et al., 1986; Beck, 1987). 
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5.2 Resistance mechanisms in RHepG2 cells 
We then sought to investigate the resistance mechanisms in RHepG2 cells. As 
mentioned in s ection 1.5, there are several mechanisms operated simultaneously i n 
cells with MDR. Since the action of doxorubicin, taxol and valinomycin is mediated 
by their action inside the cells, we wonder if there is a resistance mechanism in 
RHepG2 cells that affects the accumulation of these xenobiotics. 
We first investigated whether the accumulation of doxorubicin in RHepG2 cells 
is affected. Different levels of doxorubicin accumulation in HepG2 and RHepG2 
cells were showed in Figure 3.2.1.1 and 3.2.1.2. Treatments with increasing 
doxorubicin concentration caused a dose-dependent accumulation of doxorubicin in 
HepG2 cells while the amount of doxorubicin in RHepG2 cells remained more or less 
the same. These observations implied the possibility of reduced uptake or enhanced 
removal of doxorubicin from RHepG2 cells. 
It has been reported that reduced intracellular doxorubicin accumulation was 
associated with P-glycop.rotein over-expression in human chondrosarcoma cell lines 
(Wyman et al., 1999). Enhanced expression of P-glycoprotein has been reported in a 
number of cancer cells treated with different chemotherapeutic drugs (Gouaze et al., 
2004) and doxorubicin (Slapak et al., 1994; Raghu et al., 1993). We therefore 
labeled the cells with a P-glycoprotein specific antibody to test for the expression 
level o f P-glycoprotein on the cell surface. As shown in Figure 3 .2.2.1, RHepG2 
cells had an enhanced P-glycoprotein expression when compared with that of HepG2 
cells. 
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In order to estimate the contribution of P-glycoprotein in doxorubicin 
accumulation, the P-glycoprotein inhibitor verapamil was employed. As can be seen 
in Figure 3.2.3.2’ pre-treatment of cells with verapamil for 2 hours before doxorubicin 
incubation increased the intracellular doxorubicin signals. This indicates that 
inhibition of P-glycoprotein activity with verapamil significantly increased 
doxorubicin accumulation in RHepG2 cells. 
It has been reported that mutations in the promoter region of the MDRl gene led 
to enhanced promoter activity (Stein et al., 1996) and is related to the responsiveness 
of cells to MDR relevant drugs (Stein et al., 1994). In order to investigate whether 
the over-expression of P-glycoprotein in RHepG2 cells is due to mutations in the 
promoter region, we therefore sequenced the downstream MDRl promoter of HepG2 
and RHepG2 cells because the downstream promoter is the most frequently used 
promoter in HepG2 cells and many other cell types (Ueda et ai, 1987b). The 
promoter we sequenced included the major and minor transcription initiation sites of 
the downstream promoter. Sequencing results showed that there was no difference 
in the sequenced MDRl promoter region between HepG2 and RHepG2 cells (Figure 
3.2.4.1). This indicates that difference in HepG2 and RHepG2 P-glycoprotein 
expression level is not likely to be due to difference in the downstream promoter 
region, but may be due to mutations in other regions or epigenetic factors. 
However, although the downstream MDRl promoter was the major promoter in 
most cells, the upstream promoter has been reported to be associated with 
P-glycoprotein over-expression in leukemia patients (Rothenberg et al.’ 1989) and 
breast cancer cell lines (Raguz et al., 2004). A number of studies suggested that 
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enhanced P-glycoprotein expression can be the result of hypo-methylation in the 
P-glycoprotein promoter region (Nakayama et al., 1998; Kusaba et al., 1999; Tada et 
al., 2000). Alternatively, gene rearrangement resulting in the generation of hybrid 
mRNA and a shift in expression control to another gene with higher endogeneous 
expression were also documented recently (Mickley et ai, 1997; Harada et aL, 2000). 
Furthermore, the expression of P-glycoprotein was also found to be regulated by the 
transcription factor YB-1, which positively regulates the MDR-1 promoter containing 
a Y box (Kantharidis et al, 2000; Bargou et al., 1997; Oda et al., 1998). Therefore, 
more work is needed to explain why RHepG2 cells expressed a higher level of 
P-glycoprotein. 
Reduced doxorubicin accumulation in RHepG2 cells may only account for part 
of the resistance mechanisms in RHepG2 cells. In many cases, resistance to an 
anti-cancer drug is associated with an orchestra of resistance mechanisms operating 
simultaneously (Stravrovskaya, 2000). Our preliminary data indicate that when we 
increased the intracellular doxorubicin concentration (in terms of doxorubicin 
fluorescence) up to a level that is cytotoxic to HepG2 cells, RHepG2 cells did not 
show a similar sensitivity to doxorubicin (data not shown). In support of this, a flow 
cytometric analysis analyzing the change in mitochondrial membrane potential of 
isolated HepG2 and RHepG2 mitochondria treated with valinomycin showed that 
isolated ‘ mitochondria from RHepG2 cells were more resistant to 
valinomycin-induced mitochondrial membrane depolarization (Figure 4.3.3.1 and 
Figure 4.3.3.2). This suggests that the resistance of RHepG2 cells towards 
valinomycin is not only due to the up-regulation of P-glycoprotein, but also due to 
certain resistance mechanisms that works at the mitochondrial level. 
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One factor that determines whether a cell undergo apoptosis is the ratio of 
pro-apoptotic to anti-apoptotic Bcl-2 proteins (Zha et a!., 1997; Korsmeyer, 1999; 
Reed, 1998; Huang and Strasser, 2000; Stoetzer et al., 1996). We therefore 
investigated the relative amounts of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) 
member of the Bcl-2 family in RHepG2 cells in comparison with that in HepG2 cells. 
We found that although there was no difference in Bax expression level between 
HepG2 and RHepG2 cells, the amount of Bcl-2 was more in RHepG2 cells than that 
in HepG2 cells (Figure 3.2.5.1 and Figure 3.2.6.1). This will increase the threshold 
of the induction of apoptosis in RHepG2 cells and at least partly account for the 
resistance of RHepG2 cells towards the cytotoxicity of doxorubicin and other 
chemical agents. 
This observation is in line with the results from a study that investigates the 
correlation between Bcl-2 and Bax expression level with in vitro resistance. In that 
, study, breast carcinoma cells with higher Bcl-2 level were associated with higher 
resistance towards the therapeutic agents, but the expression level of Bax was found 
to be not correlated with sensitivity towards the anti-cancer drugs tested (Yang et al., 
2000). However, in contrast to this finding, decreased Bax level and unchanged 
Bcl-2 level was found to be the resistance mechanism to apoptosis induced by 
hydrogen peroxide in human premonocytic U937 cells (Fukamachi et al,, 1998). 
Nevertheless, these observations agree with a general conclusion that disruption of the 
apoptotic pathway at the pre-mitochondrial level is very common in cancer cells 
(Johnstone et al., 2002). 
Beside the over-expression of P-glycoprotein and Bcl-2, our colleagues also find 
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that RHepG2 cells have a higher topoisomerase II and MnSOD level than that of 
HepG2 cells. Up-regulation of MnSOD was found to promote cell survival to a 
number of death stimuli (Hur et al” 2003; Manna et al, 1998; Hirose et al., 1993; 
Wong et al., 1 989). Over-expression o f topoisomerase II, on the other hand, was 
found to be associated with patients' response to anthracycline-based regimens 
(Cardoso et al, 2004). Taken together, RHepG2 cells exhibits a number of 
resistance mechanisms at different levels. RHepG2 cells may represent a useful 
model for the s tudy o f multi-drug resistance m echanisms and d evelopment o f new 
chemotherapeutic strategies in overcoming multi-drug resistance in the treatment of 
HCC. 
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Chapter 6 
Discussion 
Effects of Polyphyllin D in 
HepG2 and RHepGl cells 
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6.1 Cytotoxicity of Polyphyllin D in HepG2 and RHepG2 cells 
In many studies, s aponins have b een shown to have p otent anti-cancer effects 
(De Tommasi et al., 2000; Lee et al., 1998; Mimaki et al., 1998). The cytotoxic 
action of saponins seems to be influenced by the structures of the sugar portion of the 
saponins, whereas the hydrophobic aglycone core is responsible for allowing saponins 
to traverse the mitochondrial membrane (Kuroda et al., 2001; F rancis e t al, 2002). 
The historical use of Paris polyphylla, the natural source of Polyphyllin D, in cancer 
treatment (www.healthphone.com) raised our interest in the efficacy of using 
Polyphyllin D as an anti-cancer drug. 
Hepatocellular carcinoma (HCC) is a prevalent cancer in the world, particularly 
in Asia-Pacific regions (Ogunbiyi, 2001). Paris polyphylla has been used in TCM to 
treat various cancers including HCC. We wonder if the saponin component of Paris 
polyphylla, Polyphyllin D also shows anti-cancer effects in HCC. Since the HepG2 
cell line shows higher stability and predictable growth, and the characteristics of 
primary hepatocytes are well-retained (Anderson et al., 2004)，we tested the 
anti-cancer efficacy of Polyphyllin D by using the HCC cell line HepG2 cells. 
MDR is a leading cause that leads to cancer therapy failure (Stavrovskaya, 2000). 
The search for chemicals that can overcome MDR mechanisms in cells has been a 
main goal in cancer research. Therefore, we also investigated the anti-cancer effects 
of Polyphyllin D in RHepG2 cells. 
By treating HepG2 and RHepG2 cells with various doses of Polyphyllin D, we 
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found that (1) Polyphyllin D has a higher cytotoxic effect than that of doxorubicin in 
both HepG2 and RHepG2 cells; (2) Polyphyllin D has similar cytotoxicity in HepG2 
and RHepG2 cells (Figure 4.1.1.1). The fact that Polyphyllin D ismoreefFective 
than doxorubicin in killing HepG2 and RHepG2 cells suggests that Polyphyllin D 
may be a more effective anti-cancer drug in treating HCC. Since a lower dose of 
Polyphyllin D can be used in HCC treatment to cause the same effect by doxorubicin, 
side effects in patients can possibly be reduced. 
Since Polyphyllin D powder is first dissolved in DMSO to give a stock of 
concentration of 50mM before further dilution with working solution, our group 
included DMSO solvent control in parallel with Polyphyllin D treatment. In 
cytotoxicity assays analyzed with MTT, 0.02% of DMSO, equivalent to DMSO 
content in 10|jM Polyphyllin D, the viability was found to be around 100% in both 
HepG2 and RHepG2 cells. On the other hand, 0.014% of DMSO, equivalent to 
DMSO content in 7}J.M Polyphyllin D, did not show significant effects in Annexin 
V/PI and mitochondrial depolarization assays. Furthermore, 0.01% DMSO, 
equivalent to DMSO content in 5 |iM Polyphyllin D, showed no obvious effect in 
H2O2 release. From these results, we can see that the apoptosis-inducing effects of 
Polyphyllin D lie in Polyphyllin D itself but not DMSO. 
In fact, the dose of Polyphyllin D used in the mechanistic studies has been shown 
to be non-toxic to mouse macrophages from BALB/c mice, and the heart and liver 
tissues of mice intravenously injected with Polyphyllin D (data not shown). 
Furthermore, although the amphiphilic property of saponins makes Polyphyllin D 
possibly hemolytic, less than 10% hemolysis was observed after treating red blood 
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cells from SD rat with Polyphyllin D (data not shown). 
Since Polyphyllin D has similar cytotoxicity in HepG2 and RHepG2 cells, it 
indicates that cytotoxicity o f Polyphyllin D in RHepG2 cells is not affected by the 
MDR mechanisms in RHepG2 cells. This raised the potential of using Polyphyllin 
D to treat HCC cells with developed MDR, and enhanced effect in co-treatment with 
other anti-cancer drugs. Similar to our findings, the ginseng saponin metabolite 
20-0-beta-D-glucopyranosyl-20(S)-protopanaxadiol (IH-901) also showed similar 
growth-inhibitory effect in the cisplatin-sensitive human pulmonary adenocarcinoma 
cell PC-14 and cisplatin-resistant cell PC/DDP (Lee et al., 1999). 
6.2 Apoptotic mechanisms caused by Polyphyllin D in HepG2 and RHepG2 
cells 
The therapeutic effects of most anti-cancer drugs are exerted by induction of 
apoptosis in cancer cells. Induction of apoptosis rather than necrosis is important in 
the sense that a "safe" removal of dying cells by apoptosis prevents the activation of 
deleterious inflammatory response (Bergmann and Steller, 2002). We thus 
investigated whether Polyphyllin D induces apoptosis in HepG2 and RHepG2 cells. 
During the termination phase of apoptosis, a number of surface molecules were 
presented onto the outer side of the plasma membrane. These surface molecules 
interact with the corresponding receptors on scavengers like macrophages, leading to 
the engulfment of the dying cells by the scavengers thus preventing the onset of 
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inflammation. Phosphatidylserine (PS) is the best characterized surface molecule 
externalized to the cell surface during apoptosis (Hengartner, 2001). During 
apoptosis, cytochrome c is released from mitochondria. Cytochrome c catalyzed 
reactive oxygen species (ROS) to attack PS to form its hydroperoxide. Oxidatively 
modified PS then undergoes spontaneous and/or scramblase-assisted extemalization 
onto the outer surface of plasma membrane (Kagan et al., 2000). 
Extemalization of PS induced by Polyphyllin D in HepG2 and RHepG2 cells 
were studies with the aid of Annexin-V and propidium iodide (PI). As shown in 
Figures 4.2.1.2 and 4.2.1.3, a larger proportion lies in the early apoptotic stage than 
the late apoptotic/necrotic stage suggesting indicates that most of the cells treated with 
Polyphyllin D die due to the induction of apoptosis rather than necrosis. 
An interesting phenomenon is observed that Polyphyllin D treatment caused a 
‘ larger proportion of cells to die in RHepG2 cells than in HepG2 cells. This is in 
contrast to the alamarBlue cytotoxicity assay which showed similar cytotoxicity of the 
Polyphyllin D-treated in HepG2 and RHepG2 cells. This discrepancy may be due to 
the fact that alamarBlue detects both the cytotoxic and cytostatic effects of 
Polyphyllin D, whereas the Annexin-V/PI assay detects the apoptotic effects of 
-Polyphyllin D. To further confirm the cytostatic effects of Polyphyllin D, we may 
perform the thymidine incorporation test with a non-toxic dose of Polyphyllin D. 
There are two main signaling pathways that lead to the execution of apoptosis. 
They include the extrinsic death receptor pathway and the intrinsic mitochondrial 
pathway (Pommier et al.’ 2004). In the extrinsic death receptor pathway, apoptotic 
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signal is transmitted from the death receptor level to intracellular level through the 
auto-activation of caspase 8 at DISC (death-inducing signaling complex) (Budihardjo 
et al,, 1999). Caspases are a family of cysteine aspartic proteases which are the core 
machinery of apoptosis (Budihardjo et al., 1999; Kumar, 1999). They are zymogens 
which are synthesized as inactive pro-enzymes that must be cleaved at conserved 
aspartate residues to generate active tetrameric enzymes (Nicholson, 1999). 
Activated caspase 8 may activate the effector caspase, caspase 3 directly in type I 
cells, or cleaves the pro-apoptotic Bcl-2 family protein Bid into truncated Bid, which 
then acts on the mitochondria to activate the intrinsic mitochondrial pathway in type 
II cells (Scaffidi et al., 1999; Li et al, 1998; Luo et al., 1998). 
To investigate whether Polyphyllin D elicits apoptosis through the extrinsic or 
intrinsic pathway, we tested if Polyphyllin D activates caspase 8, a key mediator of 
the extrinsic death receptor pathway. Western analysis indicates that there is no 
‘ activation of caspase 8 after Polyphyllin D treatment (Figure 4.2.2.1). To further 
confirm this, we employed HK-Pl, a fluorescent derivative of Polyphyllin D, to 
visualize the distribution of the drug in cells. Images from fluorescence microscope 
showed that HK-Pl is not exclusively distributed around the plasma membrane of 
cells, but rather, they are distributed throughout the cells (Figure 4.2.3.2). This 
-indicates that it i s not 1 ikely that Polyphyllin D binds to death receptors to induce 
apoptosis through the extrinsic pathway. One interesting phenomenon observed was 
that t here w ere s mall s pots o f h igher fluorescence in the n uclei o f the c ells. This 
shows that HK-Pl may associate with the nucleoli to elicit its effects. Further 
experiments were needed to confirm its action in the nucleus. 
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Many saponin-induced apoptoses are caused by activation of the intrinsic 
mitochondrial pathway (Liu et al., 2000; Haridas et al., 2001; Yui et al., 2001; Cai et 
ai, 2002). In the intrinsic pathway, cell death is largely controlled by the Bcl-2 
family proteins. The anti-apoptotic proteins in the Bcl-2 family, such as Bcl-2 itself 
and BC1-XL, prevent the onset of apoptosis whereas the pro-apoptotic members of this 
family like Bax, Bid and Bad promote apoptosis (Newmeyer and Ferguson-Miller, 
2003). The balance of the pro- and anti-apoptotic members of this family determines 
the onset of apoptosis by controlling mitochondria membrane permeabilization (MMP) 
(Danial and Korsmeyer, 2004) (Review: Kroemer and Reed, 2000). 
The effects of Polyphyllin D on the anti-apoptotic Bcl-2 family protein B cl-2, 
and the pro-apoptotic Bcl-2 family protein Bax were investigated with Western 
analysis. From Figures 4.2.4.1 and 4.2.5.1, we can see that Polyphyllin D has no 
effect in Bcl-2 protein expression in both HepG2 and RHepG2 cells. In contrast, 
PolyphyllinD enhanced Bax protein expression inboth HepG2 andRHepG2 cells 
after 24 hours treatment. This showed that Polyphyllin D reduced the ratio 
Bcl-2/Bax ratio in treated cells. 
Induction of MMP always involves outer mitochondrial membrane 
permeabilization that leads to the release of a number of proteins that are normally 
confined to the intermembraneous space. Cytochrome c and apoptosis-inducing 
factor (AIF) are two important intermembraneous mediators of apoptosis that are 
released in response to MMP (Ravagnan et al., 2002). To confirm that Polyphyllin 
D induces apoptosis in HepG2 and RHepG2 cells through the intrinsic mitochondrial 
pathway, the release of cytochrome c and AIF were investigated with Western analysis 
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(Figure 4.2.6.1 and 4.2.6.2). We found that Polyphyllin D treatment caused the 
release of both cytochrome c and AIF into the cytosol, leading to the progression of 
apoptosis. •“ 
Apoptotic MMP may affect the outer mitochondrial membrane and the inner 
mitochondrial membrane in a number of fashions. Inner membrane permeabilization 
seems to be a less constant feature of apoptosis (Kroemer and Reed, 2000). In 
normal circumstances, the inner mitochondrial membrane is almost impermeable to 
cytosolic components. This allows the respiratory chain to create an electrochemical 
gradient which is indispensable for driving the ATP synthase to phosphorylate ADP to 
ATP (Kroemer and Reed, 2000). Disruption of the inner mitochondrial membrane 
has two implications. First, permeabilization of the inner mitochondrial membrane 
depolarizes the mitochondrial transmembrane potential, thereby stopping the 
production of ATP in cells which is necessary for all living organisms. Second, 
damage of inner mitochondrial membrane releases various respiratory chain 
intermediates into the cytosol. The release of reactive oxygen species (ROS) such as 
hydrogen peroxide (H2O2), hydroxyl radicals (.OH) and superoxide anions (O2") from 
the mitochondrial matrix have been shown to damage chromosomal DNA and other 
cellular components, resulting in DNA degradation, protein denaturation, and lipid 
-peroxidation (Higuchi, 2003). 
In many studies, both the outer and inner mitochondrial membranes were found 
to be permeabilized after drug treatment. In the hydrogen peroxide induced 
apoptosis in teratocarcinoma cell line NT2, both cytochrome c release and 
mitochondrial membrane depolarization was observed, which represents the 
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permeabilization of both outer and inner mitochondrial membrane (Cardoso et al” 
2004). Similar observations were found in a-mangostin induced apoptosis in PC 12 
rat pheochromocytoma cells (Sato et al., 2004). In some studies, on the other hand, 
release of cytochrome c may occur in cells whose mitochondrial transmembrane 
potential was normal or even increased (Green and Reed, 1998). 
In the light of this, we investigated whether Polyphyllin D treatment also affects 
the integrity of the inner mitochondrial membrane by detecting changes in the 
mitochondrial transmembrane potential after Polyphyllin D treatment. From Figure 
4.2.7.1 and 4.2.7.2, we can see that Polyphyllin D caused mitochondrial 
depolarization in HepG2 and RHepG2 cells in a dose-dependent manner. Again, it is 
obvious that Polyphyllin D is more effective against RHepG2 cells than HepG2 cells. 
Morphological and distribution changes in mitochondria in HepG2 and RHepG2 
have also been investigated. By using confocal microscopy, we found that 
Polyphyllin D caused mitochondrial swelling in HepG2 cells and mitochondrial 
aggregation in both HepG2 and RHepG2 cells (Figure 4.2.8.1 and Figure 4.2.8.2). 
Mitochondrial swelling is a feature of mitochondrial inner membrane 
permeabilization which caused by the influx of hypotonic solution from the cytosol 
into mitochondrial matrix. As suggested previously by our group (Suen et al., 2000) 
and others, mitochondrial aggregation occurs during apoptosis, but the underlying 
mechanism for this is not fully elucidated (Takada et al., 1999; Desagher and 
Martinou, 2000). More recently, Haga and colleagues (2003) suggested that 
mitochondrial aggregation happens before cytochrome c release and is caspase 
3-independent. Since F as-mediated apoptosis c aused m itochondrial aggregation in 
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type II cells but not in type I cells, mitochondrial aggregation seems to occur 
exclusively in mitochondria-dependent apoptosis and suggests that mitochondrial 
aggregation may be an important step for the mitochondria-dependent apoptosis 
(Haga et al., 2003). This view is supported by Frank and co-workers (2001) who 
found that inhibition of the dynamin-related protein (Drp) 1 that mediates outer 
mitochondrial membrane fission blocked apoptosis since mitochondrial morphology 
and cellular distribution are regulated by mitochondrial fusion and fission. 
For unknown reason, serum deprivation did not cause mitochondrial aggregation 
in HepG2 cells with advanced phase of apoptosis. Whether it is due to dissociation 
of the aggregated mitochondria in late-phase apoptosis or mitochondrial aggregation 
is a stimuli-specific response awaits further investigation. 
From the figures obtained, we observed prominent mitochondrial aggregation in 
RHepG2 cells. However, we cannot tell whether mitochondria in RHepG2 cells are 
also swollen from the confocal images. Yet, mitochondrial swelling in HepG2 and 
RHepG2 were shown by flow cytometric analysis after Polyphyllin D treatment in the 
mitochondria isolated from HepG2 and RHepG2 cells (Figure 4.3.4.1). 
. For the untreated HepG2 and RHepG2 cells, they showed different morphology 
after JC-1 staining. Whereas HepG2 mitochondria were elongated, those of 
RHepG2 cells were relatively round-shaped (Figure 4.2.8.1 and Figure 4.2.8.2). The 
same observation is found in untreated mitochondria from HepG2 and RHepG2 cells. 
Higher FSC reading of the mitochondria isolated from RHepG2 cells in flow 
cytometric analysis indicates that RHepG2 mitochondria were larger in size than 
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HepG2 mitochondria (Figure 4.3.4.1). In addition, previously in our group, we 
found previously that RHepG2 cells have higher mitochondrial mass than that of 
HepG2 cells as evidenced by MitoTracker green fluorescence (data not shown). All 
these lines of evidence showed that the properties of HepG2 and RHepG2 
mitochondria are intrinsically different, and this may also account for the higher 
toxicity of Polyphyllin D in RHepG2 cells is Polyphyllin D is a 
mitochondria-targeting agent. 
Beside mitochondrial membrane depolarization, intracellular ROS level was also 
investigated after Polyphyllin D treatment. As shown in Figure 4.2.9.1，a 
dose-dependent increase in intracellular H2O2 level was observed after Polyphyllin D 
treatment. Consistent with the PS extemalization and mitochondrial membrane 
potential assays, Polyphyllin D is more effective in RHepG2 cells than in HepG2 cells. 
Also, we investigated the protective effects of N-acetylcysteine (NAC) on Polyphyllin 
D induced cytotoxicity. Our results (Figure 4.2.9.2) show that pre-treatment of cells 
with NAC protected HepG2 and RHepG2 cells from cell death. This confirmed the 
fact that H2O2 release is involved in the Polyphyllin D induced apoptotic response. 
Similar observations in saponin-induced apoptotic mechanism have been 
-reported in other groups. Wang and co-workers (2004) found that DRG, a triterpene 
saponin induced apoptosis in human colon carcinoma cells HCT-15 with hallmarks of 
intrinsic apoptotic pathway activation such as cytochrome c release, mitochondrial 
depolarization and r educed B cl-2-to-Bax ratio. Saponins from soyabeans {Glycine 
max L.) are also reported to induce apoptosis in SNB 19 human glioblastoma cell with 
mitochondrial membrane depolarization and cytochrome c release (Yanamandra et al.. 
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2003). 
The role of lysosomal rupture has recently been shifted from destroying cells 
with necrosis to the initiation of apoptosis (Brunk et al., 2001). For the involvement 
of lysosomes in Polyphyllin D-induced apoptosis, staining with low-dose AO revealed 
that lysosomal rupture was associated with the challenge of HepG2 and RHepG2 cells 
with Polyphyllin D (Figure 4.2.10.1 and Figure 4.2.10.2). However, from our results 
we cannot determine whether lysosomal rupture is a primary effect of, or a secondary 
effect mediated by Polyphyllin D on other proteins or organelles like mitochondria. 
Nevertheless, since HepG2 cells maintained their normal overall morphology during 
lysosomal rupture, this indicates that the release of enzymes from lysosomes, at least 
in HepG2 cells, is a relatively late event of apoptosis. Yet, lysosomal rupture is 
more obvious in RHepG2 cells than that in HepG2 cells for the same treatment. This 
supports our previous findings that Polyphyllin D is more cytotoxic to RHepG2 cells 
than HepG2 cells. 
The role of lysosomes in apoptosis has been suggested by many researchers. A 
number of lysosomal proteases called cathepsins have been implicated in the 
induction of apoptosis (Ferri and Kroemer, 2001). In pro-oxidant-induced apoptosis, 
Jhe release of cathepsin D from lysosomes can precede the release of cytochrome c 
from mitochondria (Roberg, 2001). Hydroxychloroquine (a cytotoxic 
lysosomotropic amine) elicited lysosomal membrane permeabilization independent of 
caspases, where mitochondrial membrane depolarization is a rate determining step for 
caspase activation (Boya et al,, 2003b). Lysosomal rupture caused by 
3-aminopropanal induced oxidative stress and mitochondrial membrane 
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depolarization in the murine macrophage cell line J774 (Yu et al,, 2003). In another 
study, the antibiotics ciprofloxacin or norfloxacin plus UV light caused lysosomal 
membrane permeabilization. This lysosomal damage in turn triggers mitochondrial 
membrane depolarization and cell death via Bax and Bak (Boya et al., 2003a). More 
work has to be done to elucidate the mechanism of Polyphyllin D in the induction of 
lysosomal rupture. 
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6.3 Site of action of Polyphyllin D in HepG2 and RHepGl cells 
Anti-cancer drugs that elicit apoptosis through the intrinsic mitochondrial 
pathway may target the mitochondria directly, or act on other organelles such as 
endoplasmic reticulum (Liu et al,, 2004) to activate the response (Green et al.’ 2002). 
Although we found that Polyphyllin D elicits apoptosis through the intrinsic 
mitochondrial pathway, we have no idea of its site of action in cells. To study this, 
we isolated mitochondrial from HepG2 and RHepG2 cells. Responses from the 
isolated mitochondrial not only tell us whether Polyphyllin D acts on mitochondria 
directly, but also the variations in the mitochondria which cannot be observed in 
whole cell assays. 
For the isolation of mitochondria, purity was confirmed with Western analysis 
(Figure 4.3.1.1). Then, the effect of Polyphyllin D treatment in outer mitochondrial 
membrane permeabilization was studies. We investigated the release of cytochrome 
c from the intermembraneous space of mitochondria, which occurs during outer 
mitochondrial membrane permeabilization. Our results (Figure 4.3.2.1) show that 
after treatment with Polyphyllin D, a dose-dependent cytochrome c release is 
observed. Similar release was observed when the isolate mitochondria were treated 
with antimycin A (data not shown). This shows that Polyphyllin D acts on the 
mitochondria directly to elicit its apoptotic effects. 
To ensure a complete overview of the action of Polyphyllin D in isolated 
mitochondria, we further tested mitochondrial depolarization and mitochondrial 
swelling after Polyphyllin D treatment by flow cytometry with the isolated 
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mitochondria to characterize mitochondrial properties. 
Results from flow cytometry showed that Polyphyllin D treatment also induces 
inner mitochondrial membrane permeabilization as indicated by mitochondrial 
membrane depolarization (Figure 4.3.3.1 and 4.3.3.2) and swelling (Figure 4.3.4.1). 
Similar to our previous observations, isolated RHepG2 mitochondria are more 
sensitive to Polyphyllin D in terms of mitochondrial membrane depolarization and 
swelling. This indicates that the mitochondria of HepG2 and RHepG2 cells are 
intrinsically different in a way that Polyphyllin D is particularly cytotoxic to the 
mitochondria of RHepG2 cells. 
In this study, we proved that Polyphyllin D is a potent anti-cancer agent that 
directly targets the mitochondria of HepG2 and RHepG2 cells. The advantage of 
using an anti-cancer drug that targets mitochondria directly is that it can evade a 
number of resistance mechanisms like the over-expression of cytosolic anti-apoptotic 
proteins like Bcl-2 and DNA repairing enzyme, or mutation in target e nzymes like 
topoisomerase II. However, this kind of drugs is also subjected to resistance 
mechanisms like oveivexpression of drug effluxes such as P-glycoprotein. 
Fortunately, from the results of our study, we found that Polyphyllin D is not a 
cross-reactant to doxorubicin and can evade the resistance mechanisms in RHepG2 
cells, including P-glycoprotein, Bcl-2, topoisomerase II and MnSOD over-expression. 
The factor that causes the higher sensitivity of RHepG2 cells towards 
Polyphyllin D treatment is likely to lie in the mitochondrion itself, rather than in the 
amount of cytosolic apoptotic mediators because this phenomenon is also observed in 
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isolated mitochondria from HepG2 and RHepG2 cells. To investigate the causes of 
the higher Polyphyllin D toxicity in RHepG2 cells, the mechanism of action of 
Polyphyllin D in HepG2 as well as RHepG2 cells should be studied. One of the 
possible targets is the mitochondrial membrane fluidity. Since saponins are 
amphiphilic in nature, their high surface activity of nature made them a possible 
modulator of the fluidity of biological membranes (Francis et al., 2002). It has been 
reported that altered mitochondrial membrane fluidity was found to affect the 
response of mitochondrial permeability transition (MPT) towards drug treatment 
(Colell et al., 2003), and the change in plasma membrane fluidity was found to be 
associated with resistance to a number of drugs (Hendrich and Michalak, 2003). The 
effects of Polyphyllin D on the properties of mitochondrial membrane fluidity them 
merit further investigation. 
� 
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6.4 Resistance reversal effects of Polyphyllin D in RHepG2 cells 
Resistance reversal effects of several ginseng saponins have been found in 
various tumours recently (Choi etal.,2003; Kim etai, 2003; Berek et a/., 2001). 
However, similar research in saponins derived from other plants is scarce. In view 
of this, we investigated the resistance reversal effects of Polyphyllin D in RHepG2 
cells. From our study, we found that long-term treatment of RHepG2 cells with a 
low dose Polyphyllin D caused significant increase in doxorubicin accumulation 
(Figure 4.4.1.1) with no change in P-glycoprotein expression level (Figure 4.4.2.1). 
This phenomenon is in line with the findings in other groups. Choi and 
colleagues (2003) found that the ginseng saponins protopanaxatrial ginsenosides 
(PTG) were able to increase daunorubicin accumulation in daunorubicin-resistant 
r 
acute myelogenous leukemia cells AML-2/D100. Similarly, the red ginseng saponin 
‘ ginsenoside Rg(3) was also found to increase rhodamine 123 accumulation in a 
number of cancer cells (Kim et al., 2003). Likewise, the resistance reversal effects 
of ginseng saponins are not due to the down-regulation of P-glycoprotein expression 
(Kim et al., 2003). Rather, interaction of the saponins with P-glycoprotein was 
found to be the mechanism that contributes to the resistance reversal effects (Choi et 
al., 2003; Kim et al” 2003). More work in this regard might help us to elucidate the 
mechanism underlying the reversal of drug resistance. 
The combined use of different drugs with distinct or overlapping effects on 
apoptotic pathways has been suggested to be a strategy in treating tumours with 
resistance properties (Abou El Hassan et al” 2004). Seeing that Polyphyllin D 
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increases doxorubicin in RHepG2 cells, and the red ginseng saponin ginsenoside Rg(3) 
enhanced the cytotoxicity of several chemotherapeutic agents including doxorubicin 
(Kim et al,, 2003), we therefore investigated the combined effect of doxorubicin and 
Polyphyllin D in RHepG2 cells. Our results revealed that co-treatment of 
Polyphyllin D and doxorubicin has increased c ytotoxic e ffect when compared with 
cells treated with Polyphyllin D or doxorubicin alone (Figure 4.4.3.1). This suggests 
that the combined treatment of cells with Polyphyllin D and doxorubicin may be a 
better therapeutic regime for cancer with MDR. It merits further investigations to 
confirm the beneficial effects of the combined treatment in cells with MDR. 
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In this study, we unraveled the potent anti-cancer effects of Polyphyllin D in 
HepG2 and RHepG2 cells along with the underlying apoptotic mechanism. 
However, we have no idea about the structural-functional relationship of Polyphyllin 
D. It has been reported that the action of saponins depends largely on the 
carbohydrate portion of the molecule, whereas the steroidal or triterpene part mainly 
associates with the ability of the saponin into cells (Kuroda et al, 2001; Francis et al, 
2002). In the future, we may synthesize different derivatives of Polyphyllin D to test 
the influence of the steroidal and carbohydrate parts on its potency in cancer cells. 
This may also give us some ideas of the action mechanism and more derivatives with 
higher potency and at the same time with fewer side effects. 
In confocal microscopy analysis, we found that Polyphyllin D treatment caused 
lysosomal rupture. Currently, we have no idea whether it is the direct effect of 
‘ Polyphyllin D in cells, or secondary to its action on mitochondria. Therefore, in the 
future, we may isolate lysosomes from cells and treat them with Polyphyllin D to see 
if the same effect in lysosomal rupture occurs. 
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The development of new drugs with little side effects which can circumvent drug 
resistance has been a main goal for cancer therapeutic designs. In this study, we 
examined the potential of using Polyphyllin D as an anti-cancer drug against HCC 
with or without MDR. In the present study, we show that Polyphyllin D is a potent 
anti-cancer drug against HCC. It is relatively non-toxic to normal tissues, and is 
more potent to the commonly used anti-cancer drug doxorubicin. The anti-cancer 
effects of Polyphyllin D are mediated by apoptosis through the intrinsic mitochondrial 
pathway. Moreover, its action on the mitochondria directly suggests that it can be a 
candidate of the mitochondrial targeting drug. In view of its additive cytotoxic 
effects with doxorubicin, Polyphyllin D may be used in both single and combined 
treatment with doxorubicin in treating HCC. Thus, Polyphyllin D is a promising 
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